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Abstract 
 
The adhesion of cells to each other and to a scaffolding matrix is a major feature of 
multi-cellular organisms. Since misregulation can have fatal consequences, thereto 
related biological processes, such as wound healing, differentiation and 
embryogenesis, are tightly regulated in space and time. To get an understanding in 
these systems it is of big interest to generate dynamically regulated platforms. In 
order to dynamically and spatiotemporally control integrin-mediated cell adhesion 
to the extracellular matrix (ECM) several systems have been establish, which can be 
controlled by an outer stimulus. Nevertheless, these methods are limited by a variety 
of drawbacks like low resolution, the use of photo-toxic UV-light or tedious synthesis 
of chemical building blocks.  
In this thesis, I present a novel optogenetic tool to control cell-matrix adhesion, 
combining in a new manner the approaches from material science with optogenetics. 
By incorporation of naturally occurring ligands for cell-matrix receptors, namely 
intergrins, like the RGD-sequence or the PHSRN-sequence into optogenetic proteins, 
they can be applied to mediated cell-surface adhesion. Surfaces coated with the 
engineered proteins can be switched either once or reversibly, by visible light in their 
ability to mediate cell adhesion. 
First, I employed the green light switchable protein CarH from T. thermophilus in order 
to switch surfaces from an adhesive to a non-adhesive state. The protein monomers 
form tetramers when the cofactor Cobalamin is incorporated and disassemble into 
dimers upon green light illumination. By incorporation of the RGD motif into the 
protein a cell adhesive building block was generated that can be immobilized on 
surfaces. Upon disassembly of the tetramer, the monomers presenting the RGD motif 
to the cell are removed and the surface is switched to the non-adhesive state. In this 
work, I showed the immobilization of proteins on the surfaces as well as their ability 
to bind integrin and disassemble under green light in vitro. Further, I confirmed these 
results in cell adhesion experiments. For the first time, I designed and implemented 
a green light-switchable system for cell-surface adhesion based on altered ligand 
presentation. 
In the second part of my thesis, I employed the blue light-switchable protein domain 
LOV2 from A. sativa to build a reversible system. This protein domain consists of a 
small protein core with a long C-terminal J!-helix, which reversibly unwinds, when 
illuminated with blue-light. I generated a library of 40 LOV2RGD mutants by insertion 
of the RGD motif at different positions in the J!-helix and by combination with 
further complementing mutations, like the PHSRN motif. The RGD peptide is caged 
by the helical conformation in dark and is presented to cells upon unwinding of the 
J!-helix under blue light illumination. I have narrowed the library to 8 promising 
mutants through characterization of the ability of the LOV2RGD mutants to bind 
integrin in dark and under blue light illumination in fluorescence anisotropy 
measurements. The selected mutants were evaluated for their ability to mediate cell 
adhesion depending on their switching state, showing significant difference in the 
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spreading area of the cells. Additionally, I determined the reversibility of cell 
adhesion on such substrates. Finally, the most promising two candidates were 
evaluated in live cell experiments, showing a significant decrease in the spreading 
area in dark but not under blue light illumination.  
In summary, I have designed and implemented two protein-based approaches for the 
dynamic control of cell adhesion using light of two different wavelengths. The green 
light-dependent CarH based system can be used to capture and release cells on 
command, whereas the LOV2 domain-based approach resembles natural timescales 
for adhesion and can therefore be used in investigations of signaling cascades or 
other processes involved in cell-matrix adhesion. In conclusion, the herein presented 
systems can overcome most of the existing drawbacks due to their sensitivity to 
visible light, their facile way to get produced in high amounts and their high spatial 
and temporal control.  
 
Zusammenfassung 
 
Die Adhäsion von Zellen zur extrazellulären Matrix (EZM) ist essentiell für die 
störungsfreie Funktion vieler Zellen. Daher ist die Interaktion von Zellen und ihrer 
Umgebung zeitlich und räumlich streng reguliert und unterliegt in Prozessen wie 
Wundheilung, Stammzelldifferenzierung und Embryogenese ständiger dynamischer 
Veränderungen. Fehlregulationen dieser Zell-Matrix Interaktionen können 
verheerende Folgen haben, wie z.B. die Entstehung von Krebs oder anderer 
unheilbarer Krankheiten. Aufgrund dessen sind für die Erforschung dieser 
pathologischen Prozesse synthetische EZM Systeme mit extern steuerbaren 
Eigenschaften interessant, die so einen Einblick in die zugrundeliegenden 
biologischen Prozesse ermöglichen. Zur dynamischen Steuerung der Zell-Matrix 
Adhäsion wurden bereits Systeme entwickelt, welche auf einen externen Stimulus 
wie z.B. Licht, Temperatur, Spannung oder pH reagieren. Vor allem Licht ist ein 
besonders geeigneter Stimulus, da es eine hohe zeitliche und räumliche Auflösung 
bietet, bioorthogonal ist und die Intensität variabel reguliert werden kann. Die 
Verwendung von photo-toxischem UV-Licht oder eine fehlende Reversibilität der 
Systeme sind immer noch große Herausforderungen in der aktuellen Forschung von 
extern-steuerbaren synthetischen EZM Systemen. 
 
In dieser Arbeit habe ich durch die Kombination von Ansätzen aus der 
Materialwissenschaft und der Optogenetik Proteine entwickelt, mit denen sich die 
Zell-Matrix Adhäsion lichtgesteuert kontrollieren lässt. Die generelle 
Entwicklungsstrategie beruht auf dem Einbau von natürlich vorkommenden EZM 
Adhäsionspeptiden, wie die RGD-Sequenz oder die PHSRN-Sequenz, in 
optogenetische Proteine. Diese Proteine reagieren intrinsisch entweder mit 
Dimerisierung oder Konformationsänderung auf Licht. Dadurch wird die Interaktion 
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der Adhäsionspeptide in den Proteinen mit Rezeptoren der Zellen, den sogenannten 
Integrinen, abhängig von der Wellenlänge des Lichts.  
 
Im ersten Teil meiner Thesis habe ich das lichtempfindliche Protein CarH aus T. 
thermophilus benutzt, um Zelladhäsion durch grünes Licht auszuschalten. Dafür habe 
ich die RGD-Sequenz an unterschiedliche Stellen in CarH eingefügt, welches im 
Dunklen eine tetramere Konformation einnimmt und durch Bestrahlung mit grünem 
Licht zerfällt. Zellen können an Oberflächen, die mit dem Tetramer beschichtet 
wurde, adhärieren und werden abgelöst, wenn das Protein, induziert durch grünes 
Licht, wieder zerfällt. Dieses System ist die erste synthetische EZM, die durch grünem 
Licht in ihrer Fähigkeit Zelladhäsion zu vermitteln schaltbar ist und stellt eine 
Alternative zu Systemen dar, die auf der UV-Licht spaltbaren Nitrobenzylgruppe 
basieren. 
Im zweiten Teil meiner Thesis habe ich ein System entwickelt, welches reversibel 
zwischen einem adhäsiven und einen nicht-adhäsiven Zustand geschaltet werden 
kann. Dafür habe ich das blau-licht schaltbare Protein LOV2 aus Avena sativa 
verwendet. Dieses Protein besteht aus einem kleinen Proteinkern und einer langen 
C-terminalen J!-Helix, welche sich reversibel unter blauem Licht entwindet. Durch 
Einbau von Zelladhäsion-Sequenzen in verschiedenen Kombinationen und 
Positionen innerhalb des Proteins habe ich 40 verschiedene licht-sensitive Mutanten 
zur Zelladhäsion generiert. Im Dunkeln sind die Bindesequenzen durch die helikale 
Konformation versteckt und können nicht von Zellen zur Adhäsion genutzt werden, 
während die entsprechenden Sequenzen durch die blau-licht induzierte Entwindung 
der Helix zur Adhäsion zugänglich werden. Durch die Bestimmung der 
Bindekonstanten der einzelnen Protein-Mutanten zu Integrin, im Dunklen und unter 
blauem Licht, konnten die Mutanten auf acht vielversprechende Variationen 
eingegrenzt werden. Zelladhäsionsstudien auf den jeweilig beschichteten 
Oberflächen zeigen in Bezug auf die Zelladhäsionsfläche eine signifikant bessere 
Zelladhäsion unter blauem Licht. Zusätzlich konnte die Adhäsion der Zellen im 
Dunklen verringert werden. Diese Ergebnisse demonstrieren die Möglichkeit, mit 
einem entsprechend veränderten optogenetischen Protein Zelladhäsion reversibel 
durch sichtbares Licht zu kontrollieren. 
Zusammenfassend habe ich in dieser Arbeit basierend auf optogenetischen Proteinen 
zwei Systeme entwickelt, welche sich mit sichtbarem Licht schalten lassen. Dadurch 
lässt sich die Zell-Matrix Adhäsion reversibel mit hoher zeitlicher und räumlicher 
Auflösung steuern und viele der Nachtteile der bereits existierenden Systeme 
konnten überwunden werden. 
   
!"#!
Acknowledgments 
 
I like to express my gratitude Prof. Joachim P. Spatz for giving me the opportunity to 
do my PhD in his group with all these wonderful members. I felt very comfortable 
here and always like a part of the group, especially at the group retreats in Antholz, 
which were always excellent in both perspectives, academically and personal. I am 
very thankful to Prof. Spatz and Dr. Seraphine Wegener that I was allowed to stay in 
Heidelberg, even when my sub-group moved to Mainz. Many thanks to Dr. Seraphine 
Wegner for the attractive topic of research, her supervision and guidance with the 
projects. Your faith in me to let me stay in Heidelberg without direct supervision 
meant a lot to me. Many thanks to PD Ada Cavalcanti-Adam to let me participate in 
her group seminars, which were a precious opportunity to get input from people 
around. 
Many thanks to the actual and the former Mainz colleagues (Simge, Lisa, Solveig, 
Samaneh, Ilke, Tanya, Fei, DongDong and Marc) for letting me feel as an equal part of 
the wegner-group. Thank you for good scientific discussions, your help with the local 
administration and for your friendship.  
I like to thank the colleagues from Stuttgart: even when we didn’t meet often enough, 
I enjoyed your company during Antholz, the group seminars and the Wasen very 
much!  
I like to thank the whole HD-Spatz with all its present and former members for 
amazing 4 years! I enjoyed having coffee or lunch breaks together, to fool around in 
the lab, have after work beer, barbecues in the sun and of course amazing times in 
Antholz! Thank you, officemates for updating me in sports, have “Doppelkekse” for 
the hangry times, having basketball challenges and answering my endless questions. 
But besides having these wonderful officemates, I made really good friends. Tina, 
Dirk, Chiara, Silvia, Rebecca, Maria and Marian, I will miss the time we spent together. 
And a special thanks to Rebecca for always having an open ear for everything, no 
matter if in personal or scientific matters, for proofreading the paper and a whole lot 
of the thesis. Your advice was and still is indispensable for me! 
I also like to thank my interns Raoul, Anna, Mareike and Svenja with whom I really 
enjoyed working together.  
Many thanks to my “chemist” friends Baucis, Basti, JFS, Yuri, Saskia, Benni, Anki, Lena 
and Melissa. Thank you for spending all the time in the lab and in the library with 
me, having thrilling kicker tournaments, lunch breaks and uncounted perfect 
evenings. You made my chemistry study an unforgettable journey! In same way, I 
want to thank my friends from home and my dear flatmates for distracting me from 
studying and for being my compensatory family. 
 
Last but not least I want to thank my family Ruth, Martin, Elena and my husband 
Fabian for endless support, help and love! Thank you all very, very much! 
 
! !  
! ! #!
Content 
! 
I. Introduction 1!
1.! CELL - MATRIX ADHESION 3!
1.1! THE EXTRACELLULAR MATRIX 3!
1.2! CELLULAR FIBRONECTIN 4!
1.3! INTEGRIN-MEDIATED CELL-MATRIX ADHESION 5!
1.4! THE CLUSTERING AND RECYCLING OF FOCAL ADHESIONS 5!
1.5! THE REGULATION OF INTEGRIN-ECM INTERACTIONS 7!
2.! SWITCHABLE SURFACES FOR CELL ADHESION 8!
2.1! STIMULI-RESPONSIVE SURFACES 8!
2.2! LIGHT-RESPONSIVE SURFACES 9!
2.2.1! CONTROLLING CELL ADHESION WITH UV-LIGHT 9!
2.2.2! NEAR INFRARED (NIR)-LIGHT RESPONSIVE SURFACES 13!
2.2.3! VISIBLE-LIGHT RESPONSIVE SURFACES 16!
3.! OPTOGENETIC BUILDING BLOCKS 19!
3.1! THE PROTEIN CARH 19!
3.2! THE LOV2 DOMAIN 21!
AIM AND MOTIVATION 27!
II. Results and Discussion 29!
4.! PHOTO-CLEAVABLE CELL ADHESION 31!
4.1! DESIGN PRINCIPLE OF GREEN LIGHT-CONTROLLED CELL ADHESION USING THE 
CARH PROTEIN 31!
4.2! INCORPORATION OF THE RGD MOTIF IN THE CARH MONOMER 32!
4.3! THE TETRAMERIC CARH PROTEINS DISASSEMBLES UNDER GREEN LIGHT 
ILLUMINATION 32!
4.4! CARH-RGD TETRAMERS CAN BE RECOGNIZED BY INTEGRIN 33!
4.4.1! THE TETRAMER BINDS TO THE SURFACE AND PRESENT THE RGD MOTIF TO THE 
SOLUTION 33!
4.4.2! INTEGRIN CAN RECOGNIZE THE RGD MOTIF AND BIND IT 34!
4.5! CELL ADHESION TO CARH-RGD 35!
4.5.1! CELLS CAN ADHERE TO DARK STATE CARH3.2 COATED SURFACES BUT NOT TO 
THE LIT STATE 36!
5.! PHOTO-SWITCHABLE CELL ADHESION 39!
5.1! PHOTO-SWITCHABLE CELL-MATRIX ADHESION WITH LOV2 MUTANTS 39!
   
!#"!
5.2! INCORPORATION OF RGD-MOTIF IN THE LOV2 DOMAIN YIELDING LOV2-RGD 40!
5.3! CHARACTERIZATION OF LOV2-RGD MUTANTS 41!
5.3.1! RECOVERY OF DARK STATE AFTER ILLUMINATION 42!
5.3.2! DETERMINATION OF THE BINDING AFFINITY OF LOV2-RGD MUTANTS TO 
INTEGRIN 43!
5.4! CELL-MATRIX ADHESION STUDIES 48!
5.4.1! CELLS CAN ADHERE TO SURFACES MODIFIED WITH LOV2-RGD MUTANTS 49!
5.4.2! FORMATION OF FOCAL ADHESIONS IN DEPENDENCE OF LOV2-RGD MUTANTS
 53!
5.4.3! REVERSIBLE SWITCHING OF CELL ADHESION 55!
5.5! IN VITRO CHARACTERIZATION OF REVERSIBLE INTEGRIN BINDING OF LOV2-RGD 
MUTANTS 58!
III.! Conclusion and Outlook 61!
6.! SUBSTRATES FOR PHOTO-CLEAVABLE CELL-SURFACE ADHESION 63!
7.! SUBSTRATES FOR REVERSIBLE CELL-SURFACE ADHESION 64!
IV. Materials and Methods 69!
8.! MATERIALS 71!
8.1! CHEMICALS AND REAGENTS 71!
8.2! ANTIBODIES 73!
8.3! KITS 73!
8.4! CELL LINES AND BACTERIA STRAINS 73!
8.5! BUFFERS AND MEDIA 73!
8.5.1! LB MEDIUM FOR E. COLI CULTURE 73!
8.5.2! MAMMALIAN CELL CULTURE MEDIA 73!
8.5.3! BUFFERS 74!
8.6! DISPOSABLES 74!
9.! METHODS 75!
9.1! SYNTHESIS OF PROTEIN MUTANTS 75!
9.1.1! CLONING 75!
9.2! PROTEIN EXPRESSION 77!
9.2.1! TRANSFORMATION OF CHEMO COMPETENT E. COLI 77!
9.2.2! PROTEIN EXPRESSION 77!
9.2.3! PROTEIN PURIFICATION 78!
9.2.4! SDS-PAGE 78!
9.3! CHARACTERIZATION OF MUTANTS 79!
9.3.1! KINETIC STUDIES 79!
! !  
! ! #""!
9.3.2! QCM-D MEASUREMENTS 79!
9.3.3! COMPETITIVE FLUORESCENCE BINDING ASSAY 80!
9.4! SURFACE FUNCTIONALIZATION 82!
9.4.1! SURFACE PEGYLATION 82!
9.4.2! CLICK REACTION ON PEGAZIDE FUNCTIONALIZED SURFACES 84!
9.4.3! DETERMINATION OF PROTEIN IMMOBILIZATION 84!
9.5! CELL EXPERIMENTS 85!
9.5.1! CELL CULTURE 85!
9.5.2! CELL SEEDING 85!
9.5.3! INDIRECT IMMUNOFLUORESCENCE OF FOCAL ADHESION PROTEINS 85!
9.5.4! STAINING AND MOUNTING 86!
9.5.5! DETERMINATION OF ADHESION AREA IN LIVE CELL EXPERIMENTS 86!
9.5.6! METABOLIC ACTIVITY TEST 86!
9.5.7! DETERMINATION OF CELL NUMBER AND ADHESION AREA 86!
9.5.8! MICROSCOPY SETTINGS 87!
9.5.9! IMAGE ANALYSIS 88!
9.5.10! STATISTICAL TESTS 88!
9.6! SYNTHESIS OF NTA-ALKYNE 89!
V. Appendix 91!
Bibliography 107!
List of Figures 112!
List of Tables 114!
Acronyms 115!
Publication List 117!
 
 
 

!!
 
 
 
 
 
 
 
 
 
 
 
 
 
  
I. Introduction 
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1.1 The Extracellular Matrix 
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1. Cell - Matrix Adhesion 
!
The interaction between cells and their microenvironment, the extracellular matrix 
(ECM), is crucial for the regulation of cellular processes such as adhesion,1 migration,2 
differentiation,3 proliferation4 and apoptosis.5 To characterize basic principles in cell 
biology and also for potential medical applications it is necessary to precisely control 
the extracellular environment of cells. Cells mostly adhere to ECM proteins such as 
fibronectin, collagen, laminin and vitronectin via integrins,6 heterodimeric plasma 
membrane receptors. In the following sections the major key player in cell-surfaces 
adhesion will be introduced.  
1.1 The Extracellular Matrix 
The ECM operates as a scaffold. Through the presentation of chemical and 
mechanical cues, the ECM influences and modulates cellular behavior. It consists of 
a variety of different proteins subdivided in two classes. These classes are fibrous 
proteins, like collagen and elastin, and glycoproteins, like fibronectin, proteoglycans 
and laminin (Figure 1.1). The respective monomers bear a variety of binding motifs, 
which are either directly recognized by integrins or linked to the cell via other ECM 
components, as e.g. fibronectin. The ECM does not only present adhesion motifs for 
cell adhesion but also actively form the tissue, influences the elastic properties of the 
tissue and regulates the availability of soluble factors, such as growth factors. 
Adhesion motifs are short amino acid sequences embedded in the ECM proteins, 
which can be recognized by integrins. Cells like fibroblasts secret ECM proteins, 
thereby remodeling the microenvironment, whereas other cells types rearrange the 
microenvironment by cleaving the ECM proteins.7,8 Hence, the interaction between 
the ECM and the cell is dynamic and reciprocal. 
 
Figure 1.1: Cells and the ECM microenvironment. Cells adhere via integrins to two different classes of 
supramolecular polymers, the fibrous proteins and glycoproteins. Collagen, laminin, elastin and 
fibronectin directly interact with integrins, while proteoglycans are bound by fibronectin, connecting 
them to the cell. Intracellular parts of integrins link the ECM to the actin cytoskeleton. Parts adapted 
from Mouw et al.1  
The major scaffolding protein is collagen but through the interplay with the other 
components, the ECM can dramatically change depending on the mechanic demands 
and functions of the tissue. Since fibronectin is a well-studied protein and features of 
Cell – Matrix Adhesion 
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it will be used within this thesis,9,10,37 the next section will focus on this protein and 
its characteristics enabling the adhesion of cell receptors.  
1.2 Cellular Fibronectin 
Cellular fibronectin (cFN) is encoded in a single gene, but due to alternative splicing 
20 variants are known in human.9 The protein is multivalent and has several binding 
sites for other ECM proteins, such as cellular fibronectin itself, growth factors and 
integrins.9 Forming a folded dimer in solution, stabilized by disulfide bonds, it can be 
straightened into fibrils upon adhesion of fibroblasts. This exposes various additional 
binding motifs for ECM ligands (Figure 1.2a+c).1 Cell-cFN interaction is driven by the 
binding of integrins to the III10 domain, containing the cell binding motif arginine-
glycine-aspartic acid (RGD),11,12 and to the synergistic site prolin-histidine-serin-
arginine-asparagine (PHSRN) in domain III9.13,14 The latter, named the synergy 
peptide, is known to increase the affinity of integrin to RGD and thereby enhance 
cell-matrix adhesion.15,16 The synergistic effect of PHSRN on integrin/RGD binding is 
highly dependent on the distance of the PHSRN motif to the RGD motif.17-19 The 
highest synergistic effect is present at a distance of 35 Å (Figure 1.2b).20-22  
 
Figure 1.2: Sketch of fibronectin. a) Linear fibronectin monomer, showing binding sites for fibrin and 
heparin in organge, for gelatin, collagen and heparin in dark grey and for fibronectin and integrin in 
purple. The arrows indicated the regions of the PHSRN and the RGD motif. In light green the motifs 
which can be rendered by alternative splicing are shown. b) The binding motifs on the III9 and III10 
domain in cellular fibronectin exhibit a distance of 35 Å. c) Fibronectin exists in two conformations: As 
a stretched dimer by application of cellular forces driving fibril formation and as a globular dimer, hiding 
the fibrin and heparin binding sides. Adapted from Mouw et al.23 and Kreiner et al.24 
The cell and its respective microenvironment are in constant communication with 
each other, exchanging signals in both directions. These signals are transduced 
through cell-surface receptors, whereas the integrin family is the most prominent of 
them and will therefore be introduced in the following section. 
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1.3 Integrin-Mediated Cell-Matrix Adhesion 
Integrins are transmembrane proteins, composed of two non-covalently associated 
subunits, ! and ". From a pool of 18 ! and 8 " subunits a family of 24 different 
integrins emerges upon heterodimerization in various combinations of the subunits.6  
The subunits consist of a big extracellular domain, a transmembrane domain and a 
small but unstructured cytoplasmic domain. Both subunits have a single helix as the 
transmembrane domain, which are intersecting and forcing the integrin monomers 
in a bent, inactivated conformation (Figure 1.3, middle).25,26 Upon binding of specific 
proteins, like talin, to the cytosolic tail of the " subunit, the interactions between the 
helices are overcome. Hence, the integrin take an upright, activated conformation 
(Figure 1.3).27 This process is known as ‘inside-out’ signaling as the activation is 
achieved by the stimulus from the cytosol. Integrins can also be activated from the 
outside by binding of ECM proteins, Mn2+ ions,28,29 and transmembrane proteins of 
other cells, as intercellular adhesion molecules (ICAMs) and E-Cadherins (titled as 
‘outside-in’ signaling). So, integrins exhibit a bidirectional signaling function within 
the cell. Depending on the combination of the subunits, integrin binds to different 
adhesion motifs in the ECM proteins. The most prominent motif is the RGD sequence.6  
 
Figure 1.3: Bidirectional signalling of integrins. The Integrin heterodimer is deactive in its bent form 
(middle). Activation occurs via outside-in activation by binding respective ligands (left) or via inside-out 
activation through binding of talin to the cytosolic integrin tail (right). Scheme adapted from Shattil et 
al.25 
1.4 The Clustering and Recycling of Focal Adhesions 
To sense environmental stimuli, mechanical and chemical signals transduced by the 
ECM are converted into intracellular biochemical signals. Since integrins lack 
enzymatic activity, the signal needs to be transduced in other ways. This is achieved 
by the aforementioned conformational changes of integrins and by the thereby 
induced assembly of clustered adhesion complexes.30 The formation of enlarged 
adhesion complexes called focal adhesions (FA) is induced upon outer stimuli. The 
first contact of a cell to an appropriate substrate induces small integrin clusters, 
α β
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called nascent adhesions, with a lifetime of about 1 min. If the cell is able to 
strengthen these clusters, over 150 proteins can be recruited to the adhesion points, 
forming mature focal adhesions. These can exhibit a half-life of about 21 min. The 
entity of all enzymes and proteins involved are titled as the adhesome.31 Because 
most of them are multi-domain ligands, they form a complex network of interacting 
proteins. Three major classes of proteins are assembled to the adhesome, or 
influenced by integrin-matrix binding. These are (1) cytoskeleton proteins, (2) 
adaptor proteins cross-linked with each other and (3) enzymes (Figure 1.4).32 If the 
cell can form mature FA, polarize and migrate, the FA are in a continuous recycling. 
In the direction of migration new FA will emerge, whereas FA at the retracting cell 
site will be disassembled. 
 
Figure 1.4: Sketch the equilibrium from nascent adhesions and the formation of mature focal adhesions 
with the simplified interplay of some FA-proteins. Adapted fromVicente-Manzanares et al.33 
Not only ligand recognition alone is able to induce FA formation, but also mechanical 
input is recognized by integrins and transduced to the adhesome, initiating signaling 
cascades.34 Talin is one of the earliest proteins localizing at the intracellular integrin 
tail during initial adhesion formation. When the adhesion sites assemble, cells apply 
endogenous tension to the ECM. If the forces thereby exceed a certain threshold 
value,35 unfolding of talin can be initiated, which allows vinculin to bind and nascent 
adhesions can maturate.36 The presence of vinculin can therefore be an indicator of 
the formation of FAs and transduction of cellular forces through integrins.37 In 
mature FAs, zyxin is recruited among many other proteins to further strengthen the 
interactions with the actin cytoskeleton.38 Since adhesion sites are highly dynamic, 
the turnover and recycling of integrins play an important role.39 Recycling of 
integrins affects inactivated as well as activated integrins. It largely varies between 
cell types and integrin types,39,40 but is a comparably fast process with an average 
half-life of less than 15 min.41,42  
Loss of ECM contact induces in most cell types a special type of apoptosis, called 
anoikis.43 This protecting mechanism is one of the key players for tissue integrity. 
Alterations in the expression levels, the recycling or in the distribution of integrins 
do often interfere with this mechanism, leading to a variety of diseases. Systems such 
1.5 The Regulation of Integrin-ECM Interactions 
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as the cardiovascular system, the dermatological system, the immune system, the 
muscle and the skeleton system can develop severe diseases by disturbance of the 
sensitive balance between the afore mentioned factors.44 In addition, cancer 
metastasis3 is highly dependent on the expression levels and types of integrins. Since 
the influence of integrins on the whole organism itself cannot be narrowed, their 
involvement in various pathways and malfunctions is of enormous interest to the 
scientific community and their potential as a therapeutic target is being 
investigated.45,46 
1.5 The Regulation of Integrin-ECM Interactions  
The regulation of integrin-ECM interactions play a major role in cell adhesion,1 
migration,2 differentiation3,47 and apoptosis.5 Therefore, integrin to matrix adhesion 
is highly important in immune response,48 wound healing49,50 and cancer 
progression.3 In wound healing the wounded site is plugged by a fibrin clot forming 
a provisional matrix. The migration of keratinocytes and fibroblast into the wound 
site is stimulated by soluble factors, but also by the ligands presented from the 
provisional ECM. Cells migrate upon signals of certain adhesion ligands and deposit 
new ECM proteins, leading to altered signaling patterns for following cells. These 
patterns are highly specific for different stages in the healing process.51 To 
characterize influencing factors in processes like wound healing in detail, it is of 
utmost interest to generate minimal systems to specifically assess distinct signals.  
The influence of ligand type and spacing52-54 of the presented ligands on cell adhesion 
and migration has been studied in great detail.15 These studies show that not only the 
spatial presentation of the ECM-cell interactions is important, also the time in which 
the cell can interact with specific ECM ligands is a crucial factor. Therefore dynamic 
systems able to tune ligand type or density in a spatiotemporal manner are of high 
interest.55,56 This can be achieved by combination of stimuli-responsive building 
blocks (reacting to stimuli like voltage, light, heat or chemicals) with ligands for cell-
surface interactions. In the next chapter a brief overview of surfaces applying 
external stimuli for alternation in ligand presentation in general, and a deeper 
insight into light-responsive systems, in particular is given. 
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2. Switchable Surfaces for Cell Adhesion 
 
2.1 Stimuli-Responsive Surfaces 
Synthetic biomaterials for biomedical applications have evolved from completely cell 
inert to more complex systems over the last decades to adequately model the natural 
ECM. Since, the effects of ligand composition, spacing, density and patterning was 
already investigated,57,58 the dynamics of natural ECM is not yet achieved with 
synthetic systems. Especially the spatiotemporal changes of ligands within the ECM 
still lacks sufficient model systems. Therefore, surfaces responding to an external 
stimulus are becoming the main focus of tissue engineering approaches (Figure 
2.1).59,60 
To build efficient stimuli-responsive surfaces for cell adhesion, three elements are 
essential: i) an external stimulus, which function as a trigger like light, voltage, heat, 
or chemicals, ii) a recipient of the stimulus, which transforms or transduces the 
stimulus, iii) a building block mediating cell adhesion. To ensure an error free input-
output correlation, surfaces conceived for stimulus-responsive cell adhesion have to 
present the chosen cell adhesion ligands but be cell inert otherwise. Self-assembled 
monolayers (SAMs) that are cell inert and can be functionalized with a ligand of 
choice is a broadly used to achieve a specific cellular response upon surface 
alteration. Alteration of the cell adhesion ligands or their exposure to the cells in 
response to stimuli, is the most direct and facile approach to control or modulate cell 
adhesion. 
 
Figure 2.1: Overview of possible stimuli-responsive modifications of the ECM for altering cell adhesion. 
Alteration of meshsizes of gel based models of the ECM, altered ligand presentation, alteration of the 
force and/or stiffness of the synthetic ECM. Adapted from Kim et al.61 
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2.2 Light-Responsive Surfaces 
Cell adhesion has been altered in response to voltage,62,63 heat,64,65 chemicals66-68 and 
light,56,69,70 but light as a stimulus provides outstanding advantages compared to other 
stimuli. First and most importantly, light is the only stimulus providing both high 
spatial and temporal resolution over the controlled interaction (Table 1). This feature 
makes light the most preferred stimulus for responsive surfaces to control cell-
matrix adhesions. Beside the spatiotemporal control, light controlled interactions 
make it possible to tuned interactions by altering light intensities or illumination 
durations and to control them noninvasively for most wavelengths of light. Further, 
different wavelengths of light can be used to trigger different interactions 
orthogonally. Light-responsive systems to control cell adhesion are typically based 
on small photo-responsive molecules (with several exceptions). In the following 
chapter, the systems for light-induced control of cell adhesion will be reviewed and 
discussed for their potential and possible disadvantages. 
Table 1: Possible external stimuli to alter stimuli-responsive surfaces. Red background color indicates 
no or little resolution, yellow indicates limited resolution and green indicates the possibility of 
subcellular resolution.  
Stimulus Spatial Resolution Temporal Resolution 
Heat Limited to the nanorod size Need relaxation time 
Voltage Limited to the electrode size Yes 
Chemicals No No 
Light Yes Yes 
 
2.2.1 Controlling Cell Adhesion with UV-light  
Photo-Cleavable Systems to Control Cell Adhesion 
One of the most widely integrated molecular building block as the stimuli recipient 
is the nitrobenzene moiety or related functional groups, which can be photo-cleaved 
upon UV-light illumination. By incorporating nitrobenzene groups into synthetic 
ECMs or surface coatings, their cell adhesive properties can be altered via light-
induced transformation of the nitrobenzene moiety. Different designs allow to either 
render cell adhesive surfaces cell inert or vice versa.71 
One design strategy is to use the nitrobenzyl group as a linker between the surface 
and a self-assembled monolayer carrying a cell-repellent poly(ethyleneglycol) (PEG). 
PEG is highly protein repellent and therefore prevents the adsorption of ECM 
proteins like fibronectin segregated by the cell and thereby the adhesion of the cell. 
Upon light illumination, the PEG group together with the nitrobenzyl is removed and 
the underlying surface is exposed. In cell culture, the newly exposed surface is likely 
to be covered by ECM proteins deposited by the cell. In addition, the surface can be 
functionalized through the unspecific adsorption of proteins from the serum,72,73 or 
polylactic acid (PLA)74 or the binding of His-tagged proteins to revealed 
nitrilotriacetic acid (NTA)75 groups. As a result, the surface can be altered from a cell 
inert state to a cell adhesive state. The nitrobenzyl group can either be attached to 
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glass surfaces through a silane or to gold surfaces through a thiol group.75 Such 
designs have been used to study the dependency of collective cell migration on 
geometric confinements and revealed that the geometry of the cell adhesive pattern 
influences the formation of leader cells.76 Drawback of this design, where the 
nitrobenzene is used as a linker to remove a PEG group in response to light, is that 
the final composition of the exposed surface is not precisely controlled since it relies 
on secondary adsorption of molecules and can change with time (Figure 2.2). 
A more defined way to turn on cell adhesion is by utilizing nitrobenzyl groups as 
caging groups on cell adhesion peptides. Several adhesion peptides including RGD 
peptide, the cyclic RGD77,78 peptide and the laminin mimetic peptide have been photo-
caged in this manner. In the first report by Petersen et al., the aspartic acid of the 
cRGD motif was photo-caged with an nitrobenzyl group, thereby blocking the cellular 
recognition by integrins. Upon UV-light illumination, the removal of the nitrobenzyl 
group resulted in the binding of integrins and the adhesion of cells. In the same study, 
confined cell patterns could be produced and retained for six hours.79 Analysis of the 
photolytic reaction of the compound revealed that an illumination time of 15 min 
was needed to fully deprotect the peptide. The long UV exposure is a clear 
disadvantage for cell viability, but allows to alter the extend of uncaging depending 
on the illumination time. Although the affinity to integrin (!#"3) increased six-fold 
upon decaging, surfaces already mediate cell adhesion in the caged state.80 However, 
for some cell types, like Human umbilical vein endothelial cells (HUVEC), the caged 
compound exhibits sufficient protection from unspecific adhesion even after 
24 hours. This allowed using this compound to study the migration of HUVEC cells in 
wound healing assays. Photo-caged surfaces for wound healing assays form an 
improved platform additionally to the standard techniques, since it avoids damaging 
of cells (like in the case for scratch assays).81  
Photo-caged peptides were used to spatiotemporally modulate cell response through 
the dynamic remodelling of their microenvironments. For example, the cell adhesion 
ligand density at specific time points has a major influence on the differentiation of 
primary cell lines. C2C12 is a fast differentiating cell line, which enables the modeling 
and investigation of the role of adhesion in differentiation. Cells were cultured on 
surfaces coated with 20 % caged cRGD compound and 80 % normal cRGD linker. The 
level of basal cRGD was increased at different time points after cell seeding by 
uncaging of the protected groups and the degree of myogenic differentiation was 
measured. Decaging during the first six hours led to a significant increase in 
differentiation. Whereas decaging after six hours showed no myogenic 
differentiation of C2C12 cells.82 Controlled differentiation of stem cells on surfaces 
was also achieved by Han et al. with a specific peptide (Pro-Phe-Ser-Ser-Thr-Lys-Thr-
Cys; PFSSTKTC) instead of RGD for mesenchymal stem cells (MSCs) adhesion. Upon 
exposure of the ligand, induced by illumination, the peptide enabled osteogenic 
differentiation, which was confirmed by staining of the obtained tissue for 
calcification.83 Specific caged ligands were not only synthesized for stem cell 
differentiation, but also for certain integrin types. A specific peptide for !5"1 
integrins was successfully caged and released, building a powerful tool to investigate 
the role and the dynamics of !5"1 integrin in processes like migration.84 Caging of 
laminin peptidomimetics led to directed neuronal growth on hydrogels 
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functionalized with the respective compound upon ligand activation.85 Caged cRGD 
was also used in hydrogel patches implanted in mouse models, showing an increase 
in vascularization of biomaterials upon presentation of the adhesion peptide by UV-
light illumination (Figure 2.2).86 The photo-caged compound was not only 
successfully applied in hydrogels, but also in poly-L-Lysine films,87 in peptide gels88 
and in PEG-based89 hydrogel systems. This provides a versatile platform of substrates 
to build 2D and 3D scaffolds with the ability of light-tuned cell adhesion on softer 
tissues.  
 
Switching surfaces from cell adhesive to inert is also possible by using nitrobenzyl 
groups as linkers between cell adhesive ligands and cell inert PEG coatings. Examples 
where the cell adhesive ligands were removed photo-chemically include  cRGD,90 
antibodies91 and biotin.92 For instance, photo-patterned biotins were used to 
immobilize any kind of biotinylated antibody through a streptavidin linker. Thereby, 
specific immune cell types were immobilized via antibody-receptor interactions and 
released when the surface linker is decomposed by UV-light. In addition to the need 
of UV-light for decaging and the lack of reversibility, the decaging efficiency highly 
depends on the caged compound and the surrounding system. Therefore, all new 
compounds need to be elaborated for their decaging behavior.93  
 
Figure 2.2: Exemplary UV-light responsive surfaces. Nitrobenzyl photo-protected surface linkers, with 
either a) PEG as a cell inert coating or b) caged cRGD. Photo-switchable surface coatings based on c) 
azobenzene switching alone or in combination with cyclodextrin as a d) host-guest complex. Adapted 
from Nakanishi et al.75 Petersen et al.79, Kadem et al.94 and Ren et al.95 
The systems mentioned above already provide a versatile toolbox to engineer light 
responsive surfaces to investigate cellular processes related with cell adhesion. One 
of their major drawbacks of photo-caging groups is the lack of reversibility. Surface 
properties can be altered only once between the cell inert and cell adhesive state in 
the direction of choice, which does not resemble the natural dynamics of cell to 
matrix adhesion.  
Switchable Surfaces for Cell Adhesion 
!+-!
 
Reversibly Switchable Systems to Control Cell-Matrix Adhesion 
To overcome the drawback of photo-caging systems, reversibly photo-switchable 
functional groups can be used as light responsive building blocks. One of the most 
widely used molecules for photo-switching are azobenzenes, which as a core 
structure have two phenylrings bridged by two doubly bound nitrogen atoms. Most 
azobenzenes switch from the trans to the cis conformation under UV light 
illumination (365 nm) and relax back either thermally or under blue light (450 nm) 
illumination. The cis to trans conformational change induces a change of the end-to-
end distance of the azobenzenes of about 3.5 Å.96 Incorporation of the azobenzene 
moiety into polymer films allowed displacement of attached groups out of the surface 
plane by switching azobenzene into the cis state and thereby hiding the attached 
group in the polymer film.  
Cell adhesion was successfully rendered photo-switchable by the incorporation of 
the azobenzene moiety into linkers between PEG films and RGD motifs.97 Surfaces 
covered with a cRGD or linear RGD functionalized azobenzene, can be switched from 
the cell adhesive trans state to the cell inert cis state and back as shown in cell 
experiments.98,99 Furthermore, atomic force microscopy (AFM) measurements 
showed that the cell adhesion force is different to the cis than to the trans state.94 In 
a related study also modified azobenzenes that can be switched to the cis state with 
green light were used, which reduces photo-toxic effects on cells. It could be 
monitored that pulsed integrin activation by high frequency switching between the 
cis and trans state, upregulated the early expression of adhesion-associated protein 
encoding genes.100 Similarly, the adhesion not through integrins but also other cell 
receptors can be controlled by changing the attached molecule. For instance, 
different cell types that express galactose and mannose specific receptors 
(asialoglycoprotein receptor and mannose receptor, respectively) could be 
specifically captured and released by attaching the respective sugars to the 
azobenzene linker. 101 In theory, other ligands, like antibodies, could also be switched 
with azobenzene as described above, but the efficiency is surely highly dependent on 
the size of the attached group and its incorporation into the polymer film. 
 
An alternative strategy to overcome the problem of insufficient caged residues, is the 
use of host-guest interactions (Figure 2.2). The designs using host-guest interaction 
are based on the fact that the trans conformation of azobenzene can intercalate into 
large organic compounds like cyclodextrin (CD). Upon cis isomerization, the kinked 
azobenzene structure cannot be hosted by the cyclodextrin anymore and hence, it is 
released. When adhesive ligands are linked to trans azobenzene, they can be 
immobilized on a CD coated surface and thereby mediate cell adhesion. Upon UV-
light illumination the azobenzene switches to the cis conformation and the adhesive 
ligand is displaced from the surface. Exemplarily linking the RGD motif to the 
azobenzene allowed to control the adhesion of Hela cells.102,103 If more selective 
ligands are linked to the azobenzene, specific cell types can be captured out of a 
mixture of cell types, monitored and released on demand. Bian et al. utilized aptamer 
(molecule-selective DNA oligonucleotides) functionalized azobenzenes, to 
 2.2 Light-Responsive Surfaces 
! +$!
specifically captured MCF-7 cells.104 Likewise, Ren et al. attached the endothelia cell 
specific peptide, arginine-glutamic acid-aspartic acid-valine (REDV) to azobenzene 
and captured endothelia cells.95 By light-induced stepwise release of the azobenzene 
ligand from the host-guest complex, the migration speed could be correlated to the 
ligand-density-dependent adhesion force to the surface. 
Bulky ligands do not sterically hinder the immobilization of azobenzenes in host-
guest complexes. However, upon displacement from the host, the azobenzene ligand 
is released and the surface needs to be recharged with the specific trans-azobenzene 
before it could be reused in cell experiments. This drawback was overcome by 
exchanging the location of the CD and the azobenzene linked adhesion ligand. 
Therefore, the azobenzene is immobilized covalently on the glass surface and the CD 
was attached via a lipid anchor to the cell membrane. This anchor is self-assembling 
within the cell membrane, coating the cells with a cyclodextrin shell. In the trans-
conformation of azobenzene, the cells can be immobilized via the host-guest complex 
formation in the interface between the cell membrane and surface and released with 
UV-light induced ligand displacement.105 
 
The introduced nitrobenzene and azobenzene based systems are already capable of 
controlling dynamically cell adhesion with light and the azobenzene based systems 
are even capable of doing so in a reversible manner. However, the employed 
wavelengths are almost exclusively UV-light bearing the risk of photo-toxicity to the 
cells. UV-light exhibit additionally low tissue penetration, making it impossible to 
employ these photo-switchable systems for medical applications. Therefore, it is of 
great interest to avoid UV-light and shift to longer wavelengths exhibiting deeper 
tissue penetration and less photo-toxicity. 
2.2.2 Near Infrared (NIR)-Light Responsive Surfaces 
In order to reduce the energy of the incident light, longer wavelengths combined 
with upconverting nanoparticles (UCNP) or surface coatings were employed. These 
materials can accept two or more photons of low energy light and emit a photon with 
high energy. Therefore, UCNP can be irradiated with NIR-light, which is then 
converted to light of shorter wavelengths, mostly UV-light, and emitted in a confined 
radius around the nanoparticle. The locally emitted UV-light can interact with 
photo-cleavable or other UV-light responsive groups without exposing the whole 
surface with UV-light, thereby reducing the risk of photo-toxic effects on cells.  
 
By combination of UCNP with UV-light cleavable linkers, NIR-light induced photo-
cleavable systems can be engineered.  Based on this concept, Li et al. linked RGD-
functionalized nitrobenzyl linkers to a gold nanorod functionalized surface. 
Fibroblast could recognize the RGD sequence and adhere to the surface. When the 
surface was illuminated with NIR-light, the light was upconverted by the nanorods 
to UV-light. Subsequently, the nitrobenzyl-linker was cleaved by the emitted UV-
light and the number of adherent cells decreased five-fold. In contrast to the 
aforementioned photo-switchable systems, this system could be used in tissue 
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engineering since it exhibits a deeper tissue penetration of the used NIR-light 
compared to UV-light. At a tissue depth of 4 mm still 40 % of the original light 
intensity was retained whereas UV-light was only detectable with 10 % of the original 
intensity (Figure 2.3).106 
 
 
Figure 2.3: NIR-light photo-switchable surface with upconversion to confined UV-light illumination by 
gold nanorods. The UV-light cleaves the nitrobenzyl group and thereby the cell adhesion linker and the 
cells detaches from the surface. Adapted from Li et al.106 
One of the main advantages of using light being its tunability, it can be applied in 
varying doses to the surface, leading to altered ligand density and thereby to changed 
signaling signals. Yan et al. used this features to control the adhesiveness of surfaces 
to directly regulate the differentiation of mesenchymal stem cells (MSCs) on photo-
switchable surface. Therefore, they immobilized a photo-cleavable PEG combined 
with RGD-PEG on UCNP functionalized surfaces. The low density of RGD-PEG was 
enough to support the adhesion of MSCs. If the surfaces are kept in dark, the stem 
cells can interact with the RGD motif and thereby keep their multipotency. If the 
nanorods are illuminated with low power NIR-light, just some of the photo-cleavable 
PEG-groups are released, leading to higher number of cell adhesion points to the 
substrate in comparison to cell-inert PEG and thereby to a differentiation of the MSCs 
to adipocytes. When the surface is illuminated with high power NIR-light, all photo-
cleavable PEGs are removed, revealing a very adhesive background. The exposure of 
the MSCs to a high percentage of adhesion molecules, induced the differentiation of 
the MSCs to osteoblasts.107 This system already altered dynamically the exposure of 
different ligand densities to cells. However, the regulation is only possible in one 
direction since photo-cleavage of the linker can only occur once.  
 
To circumvent this problem UV-light responsive photo-switchable linker can be 
combined with UCNP functionalized surfaces. Thereby the illumination with UV-
light is avoided and a dynamically reversible system can be generated. Li et al. 
coupled a spiropyran terminated linker to upconverting nanoparticles in order to 
reversibly switch cell adhesion with long wavelength stimulation. Spiropyran is an 
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organic compound which exists in two polar isomerization forms, and can undergo 
reversible ring-closing and ring-opening interconversion. The closed-ring isoform is 
neutral and therefore lipophilic, whereas the open-ring isoform is a zwitterion and 
therefore hydrophilic. The interconversion to the open form can be initiated by UV-
light, whereas light of longer wavelength lead to conversion to the closed form. 
Combination of this feature with UCNP coated surfaces, generates surfaces which can 
be reversibly switched between the two isomerization forms by application of NIR-
light. The neutral, lipophilic form favors the deposition of ECM proteins from the cell 
or the serum and thereby cell adhesion. By irradiation with high energy NIR-light, 
resulting in surface material induced upconversion to UV-light, the spiropyron 
isomerizes back to the zwitterionic open ring, and therefore hydrophilic form. The 
hydrophilic form is protein repellent, which leads to detachment of adsorbed 
proteins and cells. The number of HeLa cells adhered to such surfaces decreased 5-
fold upon conversion from the neutral to the zwitterionic isoform. It was shown that 
these surfaces can be switched about twenty times without efficiency loss, but since 
cell adhesion here depends on the deposition of proteins from the medium, the 
adhesion mediating layer is not characterized and therefore hard to control.108  
 
Upconverting nanoparticles convert high energy NIR-light to short wavelength light. 
However, they also exhibit the capability of generating heat with low energy NIR-
light, based on the photo-thermal effect. This can be used to indirectly alter cell 
adhesion with heat. Therefore, either the heat induced detachment of protein layers 
deposited of the cell or from the serum can be applied or specific heat responsive 
systems like DNA (and their assembly of the complementary strands) or the polymer 
poly(N-isopropylacrylamide) (pNIPAM) can be coupled to UCNP functionalized 
surfaces and thereby regulated indirectly with light. 
If cells are cultured on glass surfaces they will segregate ECM proteins and thereby 
generate a matrix to adhere to. This is only possible if the surfaces are not protein 
repellent, as in the case of PEG coated glass. Not only the surface coating is important 
for deposition of ECM proteins, but also the temperature. High temperatures lead to 
detachment of the adsorbed protein layer from the surface and thereby to 
detachment of the adhered cells, as shown by Giner-Casares et al. They produced an 
anisotropic gold nanostructured surface by coating gold nanoparticles on the surface 
and subsequent growth of these seed crystals. The generated topographic features of 
an anisotropic gold nanostructured surface promote cell adhesion in comparison to 
flat substrates. Illumination of the gold structured surface with low intensity NIR-
light, led to local heat generation and thereby to detachment of the covering proteins 
and cells.109 The system can be used to detach cell sheets from the surface, but 
relatively long illumination times (up to 40 min) are needed to detach the cell layer.  
To more precisely alter the ligand presentation to the cells, DNA strands can be used. 
DNA strands assemble with their complementary strand, but upon a specific 
temperature, called the melting temperature (Tm), the strands disassemble. This 
feature can be used to alter cell adhesion indirectly via heat by combination of DNA 
strands and UCNP. Therefore, one DNA strand is immobilized on UCNP coated 
surfaces, whereas to the complementary strand a ligand of choice is fused. The 
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complementary strand assembles with the immobilized DNA strand and thereby coat 
the surface with the respective ligand. The double strand was consequently 
disassembled by NIR-light induced local heat generation above the Tm, leading to 
release of the adhesion peptide and thereby of cells.110,111 This solved the problem of 
nonspecific adhesion to ECM proteins deposited on the surface. However, the DNA 
complementary strands were diluted after release, causing the need of recharging 
the surface with the appropriate DNA before reuse.  
 
Combination of upconverting substrates and immobilized thermal responsive 
building blocks can avoid ligand dilution. Polymers like PNIPAM react to heat with 
conformational changes. PNIPAM exhibit a brushed, hydrophilic conformation when 
kept below the critical solution temperature of 39 °C. When the temperature is 
increased above this critical solution temperature, the polymer collapses into a 
hydrophobic conformation. As aforementioned, proteins from cells or serum adsorb 
on lipophilic substrates, but not on hydrophilic. This effect was utilized by Cui et al. 
by functionalizing silicon nanowires covalently with the thermal responsive 
pNIPAM. If the surface is deactivated, the PNIPAM is hydrophilic and thereby protein 
and cell repellent. Upon NIR-light illumination, local heat will be generated by the 
photothermal effect of the silicon nanowires, leading to collapsed, hydrophobic 
pNIPAM. Upon hydrophobic-lipophilic interaction with the cell, cells were captured 
between the nanowires. Cells could be released when the surface was cooled below 
the critical temperature and the polymer take again the brushed, hydrophilic 
conformation. The surface could be switched twenty times effectively without 
performance reduction, but since the experiments were performed in fetal bovine 
serum (FBS) supplemented medium the deposition of ECM proteins cannot be 
excluded.112 Also the cells are only captured by lipophilic interactions with the 
polymer, so no adhesion receptors are employed and cells cannot spread.  
 
NIR-light responsive systems have the advantage to respond to long wavelengths but 
the systems are quite complex and the production of nanoparticles is not facile. In 
case of UV-light responsive systems the dose of UV-light can be reduced by 
employing upconverting materials, but not fully abandoned. Heat as a stimulus lack 
the advantages of the high spatial and temporal control of light and can have 
negative effects on cells when they are exposed too long. The development of facile, 
longer-wavelengths-of-light responsive surfaces, is therefore an ongoing research. 
Only a few systems responding to visible-light are contemporary known, which will 
be introduced in the following section. 
2.2.3 Visible-Light Responsive Surfaces 
There are only a few examples of controlling cell adhesion with visible light. One 
example is the aforementioned green-light switchable azobenzene covered surface, 
which was only established for push-pull activation of integrin,100 and not tested for 
cell adhesion so far. The approaches to generate surfaces for visible light responsive 
cell-adhesion differ enormously and are facing still many drawbacks. 
 2.2 Light-Responsive Surfaces 
! +(!
One possibility to alter cell adhesion with visible light was taken by Wang et al. They 
utilized, a boron doped silica surface, which was coated with collagen-I. Cells were 
grown on top, forming a cell sheet. Upon visible light illumination, the electron 
deficient boron enrich electrons, thereby gathering negative charge and 
consequently leading to desorption of the covering protein layer including adherent 
cells.113  
Another light-responsive surface responding to visible light, is based on a dopamine 
related molecule, which can switch between a hydrophobic, open form and a 
zwitterionic, closed form by visible light. Surfaces functionalized with this compound 
can either be hydrophilic so that they are protein repellent and cell inert, or a 
hydrophobic so that cells seeded on top can segregate ECM proteins and adhere to 
the surface. Upon green light illumination, the compound switches to the 
hydrophilic form, leading to detachment of adsorbed proteins and cells. The 
compound can be switched back in dark it can and the cell attractive state can be 
recovered. The compound is stable for up to eight switching cycles. A major 
disadvantage is that the surface needs to be switched back to the lipophilic 
conformation in toluene, making it impossible to reversibly switch cell adhesion.114 
 
Despite important progress in bio-instructive materials,115 it remains a big challenge 
to spatiotemporally control cell adhesion in a reversible and noninvasive way. One 
of the most recently published studies employed photo-switchable proteins as a 
building block for light-mediated cell adhesion. In this study, two protein pairs that 
interact in a light dependent manner were used to mediate the interaction between 
cells and surfaces. Cryptochrome 2 (CRY2) interacts with N-truncated CRY-
interaction basic helix-loop-helix protein 1 (CIBN) under blue light and phytochrome 
B (PhyB) interacts with phytochrome interacting factor 6 (PIF6) under red light. Both 
of these protein interactions reverse in dark. The proteins CRY2 or PhyB were 
expressed on the surfaces of MDA-MD-231 cells, which allowed them to attach to 
surfaces functionalized with their complementary interaction partners under blue 
or red light, respectively.116,117 Further, in the dark the protein interactions reversed 
and the cells were released. It was shown that the cells can be captured and released 
reversibly several times on the same surface. Since the proteins are responding to 
orthogonal wavelengths, also specific immobilization of one cell type was be 
achieved in the presence of the other cell type (Figure 2.4). Besides that this approach 
requires the generation of stable cell lines, it does not employ natural adhesion 
molecules and does not connect the adhesions to the cellular signaling machinery.  
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Figure 2.4: Schematic illustration of immobilization of specific cell types utilzing hetero-dimerizing 
protein pairs. Displayed in red: the red light induced heterodimerizing protein pair PhyB and PIF6; 
diplayed in blue: the blue light heterodimerizing protein pair CRY2 and CIBN. Adapted from Yüz et 
al.116 
Photo-switchable proteins offer a great possibility to generate surfaces for light-
induced reversibly switchable cell adhesion.118 Besides, the bio-orthogonality and the 
facile way to generate the proteins by bacterial expression, a full library of proteins 
reacting in diverse manner to a broad range of wavelengths, is already accessible.  
In the scope of this thesis photo-switchable proteins were engineered to mediate cell-
matrix adhesion. Therefore, the optogenetic proteins CarH and LOV2 applied in this 
work will be introduced in the following section. 
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3. Optogenetic Building Blocks 
 
The term optogenetics describes photo-responsive genetically encoded proteins. The 
tool box of optogenetic building blocks is equipped with a variety of different 
proteins, which can react to distinct wavelengths, covering the whole visible range 
of the electromagnetic spectrum.119 Early examples were mostly used in neuronal 
science. However, the field of non-neuronal optogenetics has been growing over the 
last decade, offering powerful tools to investigate intracellular processes using 
light.119,120 Within this thesis, two photo-responsive proteins were employed. The 
CarH from Thermus thermophilus and the LOV2 domain from Avena sativa, which are 
described more detailed in the following sections. The engineering principles of 
photo-responsive proteins121,122 and applications of other photoreceptors is nicely 
discussed elsewhere123 and will not be part of this section. 
3.1 The Protein CarH  
CarH is a transcription repressor in Myxococcus xanthus or Thermus thermophilus, but 
related variations exist in many different bacterial strains. CarH consists of three 
domains, a winged DNA-binding domain at the N-terminal, a four-helix bundle light-
sensing domain and a C-terminal Rossmann-fold cofactor binding domain.124 The 
cofactor for the CarH gene repressor family is adenosylcobalamin (AdoCbl, vitamin 
B12). AdoCbl assembles into the helix bundles, being coordinated by an axial 5’-
deoxyadensosyl ligand. Upon cofactor incorporation, the CarH protein assembles 
into tetramers and binds to DNA at specific operons. Tetramers assemble first by 
head-to-tail dimer formation and latter formation of a dimer of dimers. If CarH from 
T. thermophilus is illuminated with green or blue light, the axial 5’-deoxyadensosyl 
ligand is exchanged by a histidine, resulting in a kinked conformation of the dimer 
and thereby in disassembly of the tetramer and DNA unbinding (Figure 3.1). Upon 
unbinding, the operon is again exposed and transcription of regulated genes is 
turned on.125 In bacteria, CarH is involved in the genetic pathway of carotenogenisis, 
being an important molecule in oxidative stress suppression. The form of cobalamin 
is important for tetramer assembly since the isoform OHCbl binds the monomer but 
does not lead to tetramer assembly.  
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Figure 3.1: a) Tetramer of CarH and the AdoCbl cofactor, displayed in pink. b) Photoconversion of 
AdoCbl (orange) to HisCbl upon green light illumination, resulting in a kinked dimer formation and in 
temtramer dissassembly. Adapted from Jost et al.125 and Kutta et al.126  
First application of CarH as an optogenetic tool was performed by Kainrath et al. In 
the study a fusion protein of the cobalamin binding domain of CarH from T. 
thermophilus with the murine fibroblast growth factor receptor 1 (mFGFR1) was 
designed. In the dark, upon receptor clustering the downstream signaling pathway 
(MAPK/ERK) was activated, which was monitored with a luciferase reporter gene 
assay. The constructs were used in human embryonic kidney (HEK) cells, leading to 
an increase in luminescence due to CarH tetramer assembly induced by receptor 
clustering. By blue or green light illumination, but not under red light or in dark, 
receptor disassembly and a decrease of luminescence could be observed. The 
application of the optogenetic growth factor receptor 1 in zebrafish embryos showed 
that in dark, effective receptor clustering and a disturbed phenotype was obtained. 
Upon light illumination the larva development was undisturbed by silencing of the 
photo-inhibited signaling pathway.127 
Another application of CarH as light sensitive building block was pursued by Wang 
et. al. by incorporation of CarH into protein hydrogels. For the preparation of 
hydrogels, CarH was included in a protein with a flexible elastin-like sequence and 
terminal SpyTag or SpyCatcher domains, which spontaneously form isopeptide 
bonds under mild conditions. The SpyTag/SpyCatcher reaction and AdoCbl induced 
assembly of CarH tetramers lead to a network formation and a hydrogel in dark 
(Figure 3.2).  
 
 
Figure 3.2: Building blocks used for assembly of green light-switchable hydrogels, the gelation in dark 
upon cofactor addition (AdoB12), as well as the disassembly upon green light illumination. Adapted from 
Wang et al.118 
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Upon green light illumination, the CarH tetramer decomposes and the hydrogel 
liquefies. This light dependent decomposition of the hydrogel was used to release 
encapsulated cells without compromising cell viability.118 Unlike other known 
optogenetic proteins, CarH is unique in its sensitivity to green light and fills a gap in 
the electromagnetic spectrum of optogenetic tools. Examples of its successfully use 
in cellulo and in material science, proves its versatility and makes it an attractive tool 
to control diverse systems externally with green light.  
3.2 The LOV2 Domain 
The light-oxygen-voltage (LOV) domain 2 is a 17 kDa domain of phototropin 1 from 
Avena sativa. Phototropin belongs to the Per-ARNT-Sim (PAS) superfamily and has 
two LOV domains, LOV1 and LOV2. In its organism of origin LOV2 is part of a blue 
light-activatable receptor kinase and phototropin is involved in the light-guided 
orientation of plants.128. The LOV2 domain consists of a small protein core, including 
five antiparallel "-sheets, and two !-helices, of which the one at the C-terminal is 
called J!-helix (Figure 3.3). LOV2 binds to the chromophore and cofactor flavin 
mononucleotide (FMN), which absorbs blue light. Upon blue light illumination, a 
bond is formed between the cofactor and a conserved cysteine in the LOV2 domain. 
This reaction leads to an overall conformational change within the protein, including 
the unfolding of the J!-helix.  
 
 
Figure 3.3: Sketch of the LOV2 domain. Displayed in blue the J!-helix, in dark grey the protein core and 
in light brown the FMN cofactor.  
The unfolding of the J!-helix follows two separate steps with two different rate 
constants: first, the inner bond formation between the FMN and the cysteine and 
second, the unfolding of the J!-helix. While the bond formation takes seconds to 
minutes, and can be easily monitored by the absorption spectrum of FMN, the 
unfolding of the helix follows within milliseconds, making it difficult to detect. Once 
illumination is stopped, protein thermally converts back to the dark state, during 
which bond between the FMN and the cysteine is broken and the J!-helix docks to 
the "-sheet again. This unique feature of switching from a highly ordered structure 
to a disordered state bears high potential for utilizing the LOV2 domain as a 
molecular switch. Activity bearing amino acid sequences can be hidden in, or 
attached to the J!-helix such that upon light-induced unfolding, they are be exposed 
and can interact with other binding partners. In general, the light controlled activity 
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in the protein can be subdivided into two parts; i) the photosensor, which is activated 
through the chromophore, and ii) an effector being induced by the active 
photosensor. Adapting this terminology to engineered LOV2 proteins, the LOV2 
domain is the photosensor and peptides hidden in or attached to the helix are the 
effectors. Hence, to retain the photo-sensory function, it is important to preserve the 
interactions between the J!-helix and the "-sheet during the incorporation of 
effectors. 
 
 
 
Figure 3.4: Sketch of the LOVTAP dimer system. Indicated in blue the LOV2 domain, in dark blue the 
J!-helix of the protein and in orange the interface of the TrpR repressor and in dark red, the helix of the 
TrpR repressor. Adapted from Strickland et al.129 
One of the first examples that use the LOV2 domain for photoreceptor engineering 
was reported by Strickland et al. In this study, the bacterial transcription repressor 
TrpR was incorporated into the LOV2 domain by fusing the terminal helix of the TrpR 
to the J!-helix. The construct was named LOVTAP (Figure 3.4).129 In the dark, the 
helix of TrpR is attached to the LOV2 domain, making it impossible for the 
transcription repressor to bind the respective DNA sequence as the TrpR binds DNA 
as a dimer in a specific conformation. Upon blue light illumination, the TrpR detaches 
from the LOV2 domain, forms the dimer and binds to its specific DNA, leading to a 6-
fold increase in DNA binding.129 Following similar design principles, a broad range of 
LOV2 based photoreceptors have been developed as optogenetic tools, enabling the 
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investigation of diverse cellular processes and their spatial and temporal control 
(Figure 3.5).  
 
Figure 3.5: Overview of cellular processes that have been or can be regulated by blue light-switchable 
optogenetic tools employing the LOV2 domain. Adapted from Losi et al.123 
For many other processes LOV2-based photoreceptors were engineered by direct 
incorporation of the effector into the photoreceptor. Not only apoptosis was induced 
by incorporation of degradation sequences into the LOV2 domain,130,131 but also 
protein functionality could be rendered by combination of the LOV2 domain and split 
inteins. Inteins are peptides, which excise themselves posttranslational, connecting 
the C and the N-terminus of the attached protein parts, forming a new, modified 
protein. By combining a split intein with a photoreceptor, this splicing can be 
induced by light, resulting in the formation of an intact protein after blue light 
illumination.132,133 The incorporation of nuclear localization sequences (NLS)134,135 or 
nuclear export sequences (NES)136,137 provide a versatile tool box of diverse blue light-
switchable localization domains for the nucleus138 or peroxisomes139 (Figure 3.6). 
 
 
Figure 3.6: Sketch of blue light-induced nuclear import and export of proteins of interest with the LOV2 
domain. Adapted from Losi et al.123 
Besides the direct incorporation of the effectors in the J!-helix, like described for the 
LOVTAP system, LOV2 based light dependent dimerizers have also been developed as 
general optogenetic platform. The general principle behind these designs is to 
include small dimerizing peptides in the J!-helix, which are caged in dark. Upon blue 
light illumination, these peptides are exposed and can dimerize with the respective 
dimerization partner. Such light dependent dimerizers are of interest to control the 
localization of proteins; if one of the components is localized at a membrane, a 
protein of interest fused to the respective binding partner can be re-localized upon 
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blue light illumination. The altered localization leads to an increase of the local 
protein concentration and thereby photo-induced activity. Mainly three systems of 
LOV2 based dimerizers have gained strong interest within the optogenetic 
community, and many studies used these tools as discussed below.  
 
Tunable, Light-Controlled Interacting Protein Tag (TULIP) 
For the tunable, light-controlled interacting protein tag (TULIP), a small binding 
peptide was incorporated at the end of the LOV2 protein (LOVpep). The peptide binds 
to an engineered PDZ domain (ePDZ) in the lit state, leading to a dimerization of the 
two proteins (Figure 3.7). When LOVpep is localized to the cell membrane, proteins 
of interest, fused to the ePDZ domain, could be localized there as well upon blue light 
illumination, as initially shown with fluorescent proteins. By fusing proteins that are 
part of signaling cascades, the mating pathway in yeast could be activated upon 
membrane localization.140 Likewise the TULIP dimerization pair was used to 
spatiotemporally control processes like organelles transport along microtubules,141 
the effect of localization/activation of the GTPases RhoA and Cdc42 on cytocynetic 
furrows,142 stress fiber formation143 and cell polarization.144 Also, clathrin-mediated145 
endocytosis as well as specific integrin signaling146 were photo-controlled employing 
the TULIP system. 
 
 
Figure 3.7: Three heterodimerzing LOV2-based optogenetic tools. a) Tunable, light-controlled 
interacting protein tag (TULIP), b) engineered light-inducible dimer (iLID) and c) LOVTRAP system 
based on dark state heterodimerization with an engineered Zdark protein and the LOV2 domain. 
Adapted from Strickland et al.147 and Losi et al.123 
Light-Inducible Dimers (LID) 
In a related approach, the SsrA peptide from E. coli was introduced in the J!-helix. 
This peptide dimerizes with a 13 kDa adaptor protein, called SspB. The original 
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approach exhibited a switching efficiency of 8-fold and an unusual fast dark 
relaxation. This protein pair, called original light-inducible dimer (oLID),148 was 
further improved by combination of computational design and phage display, 
generating initially two light inducible dimerization pairs with different dynamic 
ranges. The improved LID (iLID) changes its affinity from 130 nM under blue light to 
4.7 µM in the dark (36-fold, SspB was named Nano in the study). Similarly, iLID 
changes its affinity (due to a point mutant of Nano) from 800 nM to 47 µM in the dark 
(59-fold, SspB was consequently named Micro). Later a third protein pair, called 
iLID/Milli with a range from 3 µM to 125 µM was published.149 The iLID/Nano(Micro) 
interaction has been used to control protein localization and activation of GTPase 
signaling by light-induced localization of the GTPase with Cdc42 at the cell 
membrane.150 Depending on the kinetics and thermodynamics of the process of 
interest, the different dimerizing pair can be chosen accordingly.151  
To determine the dynamic range of the proteins, fluorescence anisotropy 
measurements were used.152 This method is based on the electronic features of 
fluorophores and their absorbance of polarized light. If a dye is excited with polarized 
light, also the emitted fluorescence is polarized in the same direction as the 
excitation. Given that the orientation of the fluorophore is not fixed between 
excitation and emission, it can move out of the polarization plane, leading to a 
decreased fluorescence signal in the original polarization direction. If the mobility of 
the fluorophore is decreased by binding of bulky compounds, the polarization 
direction of the excitation is retained to a higher degree. The anisotropy is a ratio 
between the vertical and perpendicular polarized emitted light and therefore a direct 
value of the mobility of the dye in the measured solution. From the motility of the 
dye the binding affinity of possible binding partners can be assessed.153 Since it is a 
fast and easy method to determine binding affinities it is often used to characterize 
optogenetic tools.149,154 
By blue light induced localization of Cdc42155,156 or PIPx phosphatase157 at the plasma 
membrane, the downstream signals and cytoskeleton remodeling could be 
monitored. The iLID interaction pair has been used to generate a blue light-
activatable calcium channel.158 Furthermore, the iLID/Nano interaction has also been 
used in synthetic systems like giant unilamellar vesicles (GUVs) to control protein 
localization and patterns of proteins of interest159 and the self-assembly of 
polystyrene beads in a light controlled manner.160 
 
 LOVTRAP 
LOVTRAP system operates differently compared to the two previously described 
systems. Instead of incorporating a binding tag into the J!-helix of the LOV2 domain, 
a small protein, Zdk, was engineered from the Z subunit of protein A, to bind the dark 
state of the LOV2 domain. Upon blue light illumination and subsequent helix 
unwinding, the ZdK protein detaches from LOV2 and diffuses to the region of action. 
This is a reverse system to further complete the toolbox of optogenetics. As proteins 
of interest the GTPases, RhoA and Rac1 as well as their upstream guanosine 
triphosphate (GTP) exchange factor Vav2 was utilized to control activity with light. 
For all three photo-regulated proteins light-induced changes in membrane ruffling, 
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spreading area and protrusion distribution of HeLa cells were observed.161 Likewise, 
LOVTRAP was also used to control microtubule dynamics with blue light.162  
 
Besides, incorporation of the effectors in the LOV2 domain, or the design of light 
controlled dimerizers, there is a third possibility to regulate protein function with 
light using the LOV2 domain. The insertion of the LOV2 domain into protein loops 
that are allosterically coupled to the active side, not conserved and accessible does 
not alter protein function in the dark state. However, upon blue light illumination 
the attached protein structure is disturbed, resulting in a loss of function. The small 
GTPases RhoA, Rac1, Src and Cdc42 and the Rac1 activator Vav2 were successfully 
inhibited by blue light-induced allosteric control with the LOV2 domain (Figure 
3.8a).163 The combination of protein design and computational selection of suited 
proteins was named Loopology.  
One of the first approaches to control cellular functions with direct incorporation of 
the effector in the LOV2 domain, was shown by Wu et al. In this study the small 
GTPase Rac1, which regulates the actin cytoskeletal dynamics to the C-terminal J!-
helix, was fused to the end of the J!-helix of the LOV2 domain. Thereby, the 
interaction of Rac1 with its effector the p21-activated kinase (PAK) was blocked. 
Upon blue light activation, the Rac1 interacts with its effector due to the helix 
unfolding. With the photo-switchable Rac1 construct (PA-Rac) transfected mouse 
embryonic fibroblast (MEF) were shown to migrate in the direction of activated PA-
Rac (Figure 3.8b).164 A follow up study could show that local Rac1 activation in 
Drosophila ovary led to clustered cell movement in direction of the highest Rac1 
activity, like known in collective cell migration, which is an important process in 
morphogenesis.165 
  
Figure 3.8: Exemplary figure of optogenetic control of Rac1. a) An allosteric photoswitch by 
incorporation of the LOV2 domain into an exposed loop of the protein RAC1 by the loopology approach. 
Displayed in blue the LOV2 domain and in red the Rac1. Adapted from Dagliyan et al.163 b) Sketch of 
the photo-controlled Rac1 by end-to-end attachment of LOV2 domain to Rac1. c) Blue light-guided cell 
migration by stimulus-control of the LOV2 caged Rac1. The yellow dot indicates the illumination site; 
the red area shows where the cell migrates to and the purple area indicated the cell area which is 
retracted upon migration. Adapted from Wu et al.164 
Since, many points have to be considered, the successful incorporation of the 
peptides into the J!-helix it still a delicate matter. Besides computational estimations 
about which positions can be or have to be rendered and the knowledge of already 
published systems, it is still difficult to generate functional mutants from scratch. A 
library of mutants has to be established and evaluated for their potential in the 
respective experiments.  
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Aim and Motivation 
 
In order to circumvent many of the afore-mentioned drawbacks, I decided to utilize 
optogenetic tools to generate light-switchable surfaces for cell-matrix adhesion, 
which are facile to produce. Therefore, I chose the green light-decomposable protein 
CarH to catch and release cell on command of non-toxic green light. To generate a 
switchable system for light-induced cell-matrix adhesion, I employed the blue light-
switchable protein domain LOV2. The reversibility of the latter system guaranties not 
only the capture of cells and on command release, but also to gain insight into 
dynamic processes within the cell when it migrates or loses matrix contact.  
For addressing natural cell adhesion ligands, like integrins, this thesis is based on 
incorporation of the RGD motif into the mentioned proteins. Since, the systems are 
not based on dimerization partners, the need to transfect and render cell lines in 
advance is avoided. Thereby, the so obtained surfaces can be used to modulate 
cellular adhesion to all cell lines presenting RGD binding integrins, without further 
manipulation. 
!!
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4. Photo-Cleavable Cell Adhesion 
 
Since light has the advantages to achieve high spatial and temporal control, I 
designed photo-responsive interphases to precisely control cell-matrix adhesions. To 
circumvent the drawbacks of current methods including tedious chemical synthesis 
and the toxicity of UV light cleavable caging groups, I used the green light responsive 
protein CarH to generate surfaces, which allow tuning cell-matrix adhesion using 
green light.  
4.1 Design Principle of Green Light-Controlled Cell 
Adhesion Using the CarH Protein 
In the first part of this thesis, I employed the light sensing part of the protein CarH 
(21 kDa) from T. thermophilus, build of a four-helix bundle and a Rossmann-fold.125 
Since the DNA binding domain is not involved in tetramer assembly, the protein was 
truncated and only the light sensing part was used. When bound to its cofactor 
vitamin B12, CarH forms a tetramer, which is photo-cleaved upon green light 
illumination. Therefore, CarH is used as a photo-cleavable molecular building block 
to alter cell adhesion. To allow cells to adhere to CarH functionalized surfaces, the 
cell adhesion peptide RGD was introduced at different positions close to the C-
terminal His-tag of CarH to yield CarH-RGD. Due to the tetrameric protein structure 
of CarH, the His-tags at two of the C-termini bind to the Ni2+-NTA functionalized PEG 
surface and the respective RGD motifs are not accessible for integrin binding due to 
the CarH protein above them. The other two C-termini face the solution and the RGD 
motifs are thereby accessible to integrin binding (Figure 4.2a). In the dark, integrins 
recognize the presented RGD motifs on top of the CarH tetramer and mediate cell 
adhesion. Upon green light illumination, the tetramer disassembles, which 
consequently leads to the detachment of the cells and the CarH monomers bound to 
integrin cell receptors (Figure 4.1). 
 
Figure 4.1: Schematic representation of the design principle to control cell-surface adhesion with green 
light. The CarH tetramer with an RGD sequence is immobilized on a surface through its His-tag on a 
Ni 2+-NTA functionalized PEG coated surface. This allows the cells to adhere to these surfaces in the 
dark via the interaction of integrins and the incorporated RGD motifs facing the solution. Upon 
illumination with green light the CarH-RGD tetramer disassembles into dimers resulting in cell 
detachment. The CarH monomere is displayed in purple, the vitamin B12 in red, the PEG is indicated 
by the blue line functionalized with a NTA-group displayed in red.  
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4.2 Incorporation of the RGD Motif in the CarH 
Monomer 
To prevent perturbation of the protein structure (Figure 4.2a) and function by the 
introduction of the RGD motifs, a site close to the C-terminal His-tag was chosen. One 
of the RGD motifs was introduced to a position where the protein sequence of CarH 
already bears the amino acids RG (underlined in the WT, Figure 4.2b), being a 
predestinated mutation site for RGD incorporation. Alternatively, the RGD motif was 
directly introduced right before the His-tag, to create a larger distance between the 
RGD motif from the folded protein core. To increase the surface density of RGD 
motifs, double and triple RGD mutants were also generated. In addition, the flanking 
amino acids from cellular fibronectin were introduced in the C-terminus, resulting 
in the following mutant library (Figure 4.2b). 
 
Figure 4.2: CarH protein structure and mutant library. a) CarH tetramer structure. Displayed in blue are 
the respective protein monomers assembled into the tetramer, the cofactor vitamin B12 is shown in 
purple, the position of the RGD motif(s) are labeled in red and in yellow the C-terminal His-tags. b) 
Amino acid sequences of the C-terminal tail of the CarH mutant library, the RGD motif is shaded in 
red, the flanking amino acids of the RGD motif from cellular FN are shaded in blue. 
The protein mutants were generated and purified like described in section 7.1 and 
section 7.2. The tetramer was formed by incubation with a four-fold excess of vitamin 
B12 on ice in the dark. For further characterization, the proteins were kept either in 
dark or under red light illumination to prevent the CarH tetramer from 
disassembling. 
4.3 The Tetrameric CarH proteins Disassembles under 
Green Light Illumination 
The vitamin B12 cofactor in the CarH tetramer and monomer has distinct absorption 
bands in its UV/Vis spectrum, which can be used to monitor the disassembly process 
of the tetramer into its monomers. Therefore, a spectrum of the protein tetramer 
was taken in dark and after different time points with green light illumination. 
Exemplary the disassembly of CarH3.2 is shown in Figure 4.3a. The arising absorption 
bands were confirmed by the results of Hardmann et al.126 The kinetics of the 
tetramer disassembly shows that an illumination time of 100 s is needed to fully 
convert the tetramer to the monomers (Figure 4.3b). 
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Figure 4.3: Green light induced disassembly of the CarH3.2 tetramer monitored by UV/Vis spectroscopy. 
a) The black curve presents the dark state, the green curves show the stepwise tetramer disassembly 
according to the illumination times, the yellow curve shows the absorption spectrum of a fully 
disassembled tetramer. b) Absorbance at 358 nm plotted over time and fit to a first order kinetic, 
indicating that an illumination time of 100 s is needed for full conversion. 
4.4 CarH-RGD Tetramers can be Recognized by Integrin 
After the tetramer formation and disassembly of different CarH-RGD mutants was 
successfully confirmed by UV/Vis spectroscopy, the orientation of the surface-
immobilized proteins as well as their capability to bind integrin was investigated. 
Therefore, immunofluorescence staining and quartz crystal microbalance with 
dissipation (QCM-D) was utilized, as described in the following section 
4.4.1 The Tetramer Binds to the Surface and Present the RGD 
Motif to the Solution  
To assess the orientation of the proteins on the surface, indirect 
immunofluorescence staining was performed to visualize the His-tags accessibility of 
the immobilized CarH-RGD. The protein tetramer of CarH3.2 was immobilized on 
glass surfaces with a PEG coating and Ni2+-NTA end group as described in section 9.3. 
While one sample was kept in the dark (dark state), another sample was illuminated 
with green light for 20 min (lit state). Subsequently, both samples were incubated 
with anti-His antibodies, which recognizes the accessible His-tags on the surface. 
Finally, the surfaces were incubated with a secondary antibody which bind to the 
anti-His antibody and is conjugated to an Alexa 488 fluorophore for detection. To 
measure the average fluorescence of each surface, the imaging parameters were kept 
constant and the fluorescence profile of the secondary antibody was measured on a 
line plot along the x-axis of the single images (Figure 4.4). 
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Figure 4.4: Fluorescence signal along a line plot of detected His-tags on surfaces functionalized with 
CarH3.2 mutant in dark (displayed in blue), illuminated with green light (displayed in green) and on a 
surface which was not incubated with protein (negative control, displayed in grey), assessed via indirect 
immunofluorescence staining of the His-tags.  
The fluorescence detected on the dark state sample functionalized with CarH3.2 
tetramer is higher than on samples not functionalized with protein. This indicates 
that the protein is successfully immobilized via the His-tags, and that at least two of 
the His-tags are accessible for antibody binding. The surface illuminated with green 
light exhibits a decreased fluorescence signal compared to the dark state surfaces, 
indicating a reduced His-tag density on the surface. The reduced fluorescence 
intensity after green light illumination shows the disassembly of the tetrameric 
protein and that the protein is immobilized with two His-tags facing the surface and 
two His-tags are facing the solution. The lit state surfaces, which are coated with the 
disassembled protein tetramer, still exhibit a significant higher fluorescence signal 
than the negative control. This hints at the fact that the His-tags at the surface are 
accessible for antibody binding. Since antibodies (35 kDa166) are smaller in size than 
the integrin heterodimers (190 kDa27,167), the binding of integrins is expected to be 
sterically more hindered and thus the integrins may not interact with the surface-
facing RGD motifs.  
4.4.2 Integrin can Recognize the RGD Motif and Bind It 
To determine whether integrin can recognize the presented RGD motifs in the CarH, 
QCM-D measurements were performed. For immobilization of the proteins on the 
gold crystals, surfaces were coated with thiol-PEGazide, forming a cell-inert SAM on 
the crystal. NTA-alkyne was clicked with copper catalyzed click reaction to the 
terminal azide groups and loaded with Ni2+. The crystals were washed and the 
frequency and dissipation baseline was measured (1 in Figure 4.5). Subsequently, the 
purified CarH3.2 tetramer washed over the crystals in dark and immobilized by 
coordination of the C-terminal His-tag with the Ni2+-NTA groups (2), leading to a 
frequency change of 45 Hz. The dissipation increase is negligible, indicating a tightly 
bound protein layer. Afterwards, the excess of protein was removed by washing (3) 
and the buffer system was switched to integrin binding buffer, containing divalent 
cations (4). 170 nM integrin fragment !#"3 was added to each crystal leading to a 
frequency change of 10 Hz (5) and thereby showing a binding of the integrin to the 
RGD motifs. After incubation time of 45 min the crystal was once again washed with 
integrin binding buffer to remove the unbound integrin fragments. After 10 min 
washing (6), one chamber was illuminated with green light for the rest of the 
experiments, in order to disassemble the protein tetramer and thereby also detach 
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the integrin fragment from the crystal (7) (Figure 4.5a, indicated with the green 
arrow). This led to an increase in frequency of almost 20 Hz, indicating the 
disassembly of the tetramer and the attached integrin fragment, which was not 
observed in the sample permanently kept in dark. After a washing step with integrin 
binding buffer (8), the resulted monomer or the tetramer, respectively, was detached 
from the crystal with imidazole containing buffer (9). By recovering the original 
buffer system through washing with buffer A, the baseline could be restored for both 
samples (10) (Figure 4.5). 
 
Figure 4.5: QCM-D measurements for the immobilization of CarH3.2 tetramer on PEGazide 
functionalized gold crystals clicked with NTA-alkyne and subsequent binding of integrin fragment !#"3 
to the RGD motifs of the protein. a) Crystals illuminated with green light at t = 120 min, showing a shift 
in frequency caused by protein decomposition initiated detachment of the protein and the integrin from 
the crystal. b) Crystals kept in dark for the whole time did not show a frequency shift at t = 120 min 
indicating no decomposition of the protein. Frequencies overtones 7, 9 and 11 are displayed in blue, the 
respective dissipation is displayed in red colors. Numbers indicate: (1) buffer baseline, (2) incubation 
with CarH3.2 tetramer in dark, (3) washing step with buffer, (4) buffer change to integrin binding buffer, 
(5) incubation with integrin, (6) washing step with integrin binding buffer, (7) switch on green light on 
a), (8) washing step with integrin binding buffer, (9) washing with imidazole containing buffer, (10) 
restoration of the original buffer system a baseline recovery. 
4.5 Cell Adhesion to CarH-RGD  
After observation of integrin binding to the CarH3.2 tetramer in QCM-D 
measurements, the different CarH-RGD mutants were used in cell adhesion studies. 
First, the influence of green light of 532 nm on the viability of human breast cancer 
(MCF7) cells was assessed with a colorimetric metabolic activity assay (Figure 4.6). In 
the MTT assay performed in five technical repeats, no decreased activity of cells 
under different intensities of green light as compared to the dark sample, was 
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observed. Further experiments were, therefore, conducted using a light flux of 
12.5 µM/m2s intensity of 532 nm green light, to guarantee complete photo conversion 
of the protein without induction of cell damage. 
 
Figure 4.6: The metabolic activity of MCF7 cells under illumination of 532 nm green light was assessed 
with a colorimetric assay, showing no decreased activity of cell cultures under different light intensities 
of green light compared to dark. 
4.5.1 Cells can Adhere to Dark State CarH3.2 Coated Surfaces but 
not to the Lit State 
To test if the cells adhere differently to CarH-RGD coated surfaces which were kept 
in the dark and which were exposed to green light, cell adhesion experiments were 
performed. For this purpose, glass surfaces were functionalized with proteins as 
described in section 7.3. After immobilization of the protein, the surfaces were 
washed and 5000 cells/cm2 were seeded in serum free medium and in dark onto the 
surfaces. Subsequently, the cells were incubated in dark or under green light for 
2 hours, and finally the samples were fixed and stained for the actin skeleton and the 
nuclei. The number of adherent cells on the respective surfaces was quantified by 
counting the nuclei in the nucleus staining and the spreading area of the cells was 
quantified using the actin cytoskeleton staining.  
Cells did not adhere to surfaces functionalized with most of the CarH-RGD mutants 
(Figure A3) in comparison to the passivation control, except for CarH3.2. This 
indicates that the RGD density on the surfaces is too low for the other mutants as 
CarH3.2 is the only CarH-RGD mutant with 3 RGD motifs and the other mutants do 
not provide enough anchor points for cell adhesion. On surfaces functionalized with 
mutant CarH3.2 cells adhered more cells in comparison to the passivation control if 
the surface was kept in the dark and the number of adherent cells decreased upon 
green light illumination. Therefore, the mutant CarH3.2 was further investigated in 
cell-adhesion experiments.  
In order to increase the density of protein on the surface, the tetramer was assembled 
and subsequently purified with size exclusion chromatography in dark (Figure A1). 
The adhesion studies were performed as described before, but with the concentrated 
protein sample. It was found that cells adhere significantly more to surfaces kept in 
dark as compared to the surfaces illuminated with green light or to the negative 
control without protein functionalization. As a positive control a surface with cyclic 
RGD, which is a very strong adhesion ligand was used. Indeed, cells adhered better to 
cRGD functionalized surfaces than to CarH3.2 surfaces (Figure 4.7a).  
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Figure 4.7: Cell-surface adhesion experiments. Cells were incubated for 2 hours in dark or under green 
light on surfaces functionalized with concentrated CarH3.2 tetramer. a) Number of cells adhering to 
surfaces in dark or under green light illumination in comparison to the passivation (negative) control 
and cRGD functionalized surfaces (positive control). Experiments were conducted in triplicates. b) 
Spreading area of cells attached to surfaces kept in dark or exposed to green light in comparison to 
cRGD functionalized surfaces. Experiments were conducted in triplicates, n > 220 cells. 10 – 90 % 
confidence interval is shown. p-values: * < 0.1, ** < 0.01, *** < 0.001, **** < 0.0001. 
In addition to the number of cells on the surfaces also the analysis of the spreading 
area on the respective surfaces showed that cells spread more on surfaces kept in 
dark than on surfaces illuminated with green light (Figure 4.7b). Not only adhesion 
points for the initial cell contact of cells with the surface were decreased as indicated 
by the cell number, but also for successful spreading of the cells. Exemplary pictures 
of cells adhered to the dark state and the lit state surface in comparison to the cRGD 
functionalized surface are shown in figure 4.8. 
 
Figure 4.8: Actin and nucleus stain of MCF7 cells either incubated on CarH3.2 functionalized surfaces 
in dark or under green light illumination, respectively, or on cRGD functionalized surfaces. In the 
merged channel: actin is displayed in red, nucleus is displayed in blue. Scale bar: 100 !m. 
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Overall, in this part of the work rational protein design was used to incorporate the 
adhesion peptide RGD found in many ECM proteins into the green light sensitive 
protein CarH, which serves as a photo-cleavable linker. The tetramer formation of 
CarH-RGD proteins and their disassembly under green light could be verified by 
UV/Vis spectroscopy and with QCM-D. The protein mutant CarH3.2, which includes 
three RGD motifs, was successfully used to alter cell adhesion in response to light; 
cells adhered well to CarH3.2 functionalized surfaces in the dark state, but almost no 
cells adhered after green light illumination. The herein presented CarH-RGD protein 
is able to mediate switchable cell-matrix adhesion in response to green light. Hence, 
the CarH protein enlarges the tool box of photo-cleavable cell adhesion from UV-
light cleavable nitrobenzenes to the first green light-switchable surfaces for cell 
adhesion, combining optogenetic approaches with material science. 
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5. Photo-Switchable Cell Adhesion 
 
The reversibly control of cell adhesion still remains a challenge. In order to establish 
a system to control cell adhesion reversibly and dynamically, a reversible 
optogenetic protein was employed. Therefore, the LOV2 domain from Avena sativa 
was chosen. As described before, the LOV2 domain can reversibly switch its 
conformation under blue light due to a bond formation between the cofactor FMN 
and an internal cysteine residue, when illuminated with blue light. The bond 
formation results in the unwinding of the long C-terminal helix, called J!-helix. This 
conformational change is reversed in the dark. Hence, this conformational change in 
protein structure can be employed for photo-switching the effector by incorporating 
the effector amino acid sequence in the sequence of the J!-helix.  
5.1 Photo-switchable Cell-Matrix Adhesion with LOV2 
Mutants 
Our design is based on the incorporation of the RGD motif into the LOV2 domain. The 
cell-binding RGD sequence can interact with a variety of integrins. Using naturally 
binding ligands facilitates the application of the approach and expands its 
applicability to a broad range of adherent cell types without the need of manipulating 
the cells. Furthermore, the motif is very small, increasing the possibility to 
successfully incorporate the motif into the J!-helix, thus minimizing potential 
disturbances of the dark state protein structure. 
The RGD motif was incorporated at different positions in the J!-helix, yielding LOV2-
RGD mutants. The proteins were expressed in bacteria and purified. Immobilization 
of the respective LOV2-RGD protein by complexation of the His-tags via surface-
bound NTA groups, led to full coverage of the surface with the protein mutant. The 
helical conformation of the J!-helix shields the RGD motif from cell recognition and 
cell do not adhere to the dark state protein. Upon blue light illumination, leading to 
unwinding of the terminal helix, the RGD-binding motif is exposed to the cell. 
Cellular integrins can bind to the RGD motif, recognize it and mediated cell adhesion. 
Thermal relaxation in the dark leads to refolding of the helix and subsequent caging 
of the RGD motif (Figure 5.1).  
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Figure 5.1: Photo-switchable cell-matrix adhesion with LOV2-RGD mutants. The RGD motif is 
introduced in the J!-helix of the LOV2 domain and caged by the helical conformation in the dark state. 
Upon blue light illumination, the helix unravels, exposing the RGD motif to the integrins and thus 
facilitating cell adhesion. The PEG-layer is indicated by the blue background.  
5.2 Incorporation of RGD-motif in the LOV2 Domain 
Yielding LOV2-RGD 
In the design of the protein library five different engineering strategies were 
followed (Figure 5.2a). To implement the RGD motif, amino acids were chosen 
exhibiting a similar polarity than RGD. Amino acids mediating the "-sheet docking 
are preserved as far as possible. These amino acids are underlined in the wild type 
(WT) sequence of the LOV2 domain (Figure 5.5). 
First, the RGD motif was introduced at several different positions in the J!-helix, 
leading to nine mutants (Figure 5.2b). The LOV2-RGD mutants are named RGD1 - 8, 
whereas RGD 1 is located at the beginning of the helix and the numbers increased in 
direction of the C-terminal of the J!-helix. 
The RGD motif was not only introduced to the end of the J!-helix but also in the 
middle and in the beginning, in order to achieve better caging. Most approaches 
mentioned in literature attached the effector to the end of the J!-helix147,148,168-171 
since it bears a higher risk to disrupt the protein structure by incorporation of amino 
acids at the beginning of the helix, but also potentially improved caging. 
 
 
Figure 5.2: a) The structure of the LOV2 domain with the J!-helix displayed in red, and the PHSRN 
motifs in turquois. b) Amino acid sequence of the J!-helix of the WT LOV2 domain and the first 
generation of mutants. Important amino acids promoting the interaction with the "-sheet are 
underlined. Amino acids, which can be exchanged to stabilize the helix docking are highlighted in 
yellow, the positions where the RGD motif was introduced are displayed in red and the context amino 
acids of the RGD motif in fibronectin are shown in blue. 
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Second, I implemented stabilizing mutations to increase the dynamic range of the 
LOV2-RGD mutants. Strickland et al.172 found several amino acids, which are involved 
in the docking of the J!-helix to the "-sheet and therefore stabilizing the dark state. 
By replacing these amino acids with amino acids allowing better hydrophobic 
interactions, the dynamic range of the protein mutants could be increased, namely 
less protein is active in the dark. I followed this approach, by substitution of the 
original amino acids (indicated in yellow in the WT sequence of LOV2, Figure 5.2b) 
with alanine.  
Third, to increase the local density of the RGD motif on the surface, different RGD-
sequence positions of the initial LOV2-RGD set were combined, resulting in LOV2 
mutants with double or even triple RGD motifs. The detailed amino acid sequences 
can be found in the appendix (Figure A11). 
Forth, it is known that the PHSRN motif can act synergistically on the binding of 
integrins to RGD and that the synergistic effect is based on the distance between the 
PHSRN and the RGD motif.16,22 Since, the helix has a distance of about 31 Å, the PHSRN 
motif can be combined with RGD motifs in the helix when localized at the beginning 
or the end of the J!-helix. Here, I exchanged original amino acid sequence with the 
PHSRN motif at positions localized either at the beginning of the J!-helix (PHSRN iii), 
in a "-sheet loop close to the end of the J!-helix (PHSRN i) or at the N-terminus 
(PHSRN ii). I investigated the effect of distance dependent synergistic influences by 
combining for example, PHSRNii with the RGD 7 mutant on integrin binding affinity 
upon helix unfolding. Due to the distance dependency, only specific combinations 
with the already designed LOV2-RGD mutants were taken (for sequences see 
appendix, Figure A11).  
Last, it is known that the RGD motif is the minimal binding motif for integrin 
adhesion, but there are several other factors playing a role in integrin-matrix 
adhesion. The studies of Hautanen et al. showed that the context amino acids of the 
RGD motif also increases cell adhesion.173 Therefore, I also implemented the framing 
amino acids of the RGD motif of cellular fibronectin into the J!-helix, namely mutant 
RGD 7c (Figure 5.2b). The incorporation was only realizable at the C-terminal end of 
the helix since proline is known to destroy !-helix conformations.  
To generate the respective protein mutants, I designed the respective primers and 
inserted the desired mutations with site directed mutagenesis polymerase chain 
reaction (PCR). The detailed nucleobases rendered by mutagenesis are listed in the 
appendix. 
5.3 Characterization of LOV2-RGD Mutants 
As described in the chapter IV (Materials & Methods) LOV2-RGD mutants were 
expressed, amplified and purified in E. coli (NiCO). Before interrogating the effects of 
the LOV2-RGD mutants in cell adhesion experiments, the proteins were 
characterized with regard to the switching kinetics. Hence, the dark state recovery 
after blue light illumination was monitored in UV/Vis spectroscopy. Furthermore, 
the binding affinity of the LOV2-RGD mutants to the integrin fragment !#"3 was 
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determined in a competitive fluorescence anisotropy binding assay in order to rank 
the LOV2-RGD mutants for their ability to bind integrin.  
5.3.1 Recovery of Dark State after Illumination 
The cofactor FMN has a distinct absorption pattern in its UV/Vis spectrum. If the 
bond between the cofactor and the core cysteine is formed these absorption bands 
disappear. Upon thermal dark state recovery, the bond between FMN and the protein 
breaks and the absorption bands are recovered. Therefore, the UV/Vis spectrum can 
be used to determine the half-life times and therefore, the kinetic of the cofactor 
recovery. The protein solution was illuminated for 1 min with blue light, and the dark 
state recovery of the FMN absorption was monitored starting 1 s after illumination 
with an interval of 18 s for 5 min, as described in section 9.3.1. The absorption at 
450 nm was measured and fit with a one-phase association curve, resulting in a half-
life time for the cofactor recovery (Figure 5.3a+b).  
The LOV2-RGD mutants were categorized according to the half-life times of dark state 
recovery. The fast switching mutants exhibit a half-life time under 50 s (Figure 5.3b), 
the medium switching mutants between 50 s and 70 s (Figure 5.3c) and the slow 
switching mutants of more than 70 s (Figure 5.3d). Mutants with the RGD motif 
incorporated at the beginning or the end of the J!-helix show a similar switching 
behavior than the WT LOV2 domain, displayed in red. Also, mutants with multiple 
RGD motifs (at the beginning or end of the helix) show a fast switching. In contrast, 
mutants with the RGD motif incorporated in the middle of the helix exhibit a 
decreased switching speed, as well as the double mutants with one of the respective 
RGD motif positions. Incorporation of the helix stabilizing mutations as well as the 
PHSRN motifs led to an increased half-life time of the dark state recovery, as shown 
below (Figure 5.3c-e). However, the reversion times of all LOV2-RGD mutants are in 
a similar range as the reversion time of the WT LOV2 domain.174-177 
 
Figure 5.3: Dark state recovery after blue light illumination monitored via the specific absorption bands 
of FMN. Indicated in red the WT LOV2 domain, the initial mutant set with a single RGD motif is 
displayed in light turquoise, the set of mutants with multiple RGD motifs are displayed in turquoise 
and the mutant set with additional stabilizing mutations are displayed in light blue. The combinations 
with the PHSRN motifs are displayed in dark blue, light green and faint dark blue for PHSRNi, PHSRNiii 
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and PHSRNii, respectively. a) Exemplary a normalized UV/Vis reversion kinetics of PHii 77 is shown, 
every 18 s a spectrum was taken. b) Plot of normalized values at 450 nm over time, fit with a first order 
kinetic. c) Fast switching mutants exhibiting a half-life under 50 s. c) Medium switching mutants 
exhibiting a half-life of 50 s – 70 s. d) Slow switching mutants, exhibiting a half-life > 70 s.  
5.3.2 Determination of the Binding Affinity of LOV2-RGD 
Mutants to Integrin 
In order to select the most promising candidates from the library of LOV2-RGD 
mutants, the binding affinity of the LOV2-RGD to the integrin fragment !#"3 
(MW = 192300 g/mol) was assessed in a competitive fluorescence anisotropy binding 
assay (Figure 5.4a). As competitor for the mutants, an RGD motif attached to the 
TAMRA fluorophore (TAMRA-RGD; MW = 960 g/mol) was used in the assay. Addition 
of LOV2-RGD to the preformed TAMRA-RGD/integrin complex, led to displacement 
of the fluorophore by LOV2-RGD and thereby to decreased fluorescence anisotropy. 
 
 Formation of TAMRA-RGD/integrin Complex 
First the amount of integrin !#"3 fragment needed to saturate 20 nM TAMRA-RGD 
fluorophore was determined by addition of integrin !#"3 fragment to a solution of 
the fluorophore (Figure 5.4b). Upon addition of integrin fragment !#"3 the 
anisotropy of TAMRA-RGD increased due to decreased mobility of the fluorophore in 
the solution. The saturation level was determined at 60 nM !#"3, which was further 
applied in all competitive binding assays as well as in the control experiments (Figure 
5.4 b, indicated by the dashed grey line). 
 
Figure 5.4: a) Sketch of fluorescence anisotropy competitive binding assay, showing high anisotropy 
upon TAMRA-RGD binding to integrin and low anisotropy when it is replaced from the complex by 
LOV2-RGD. b) Titration of integrin fragment !#"3 to TAMRA-RGD, yields in saturation of the 
fluorophore at 60 nM, indicated by the dashed line. Experiment conducted in triplicates. 
To eliminate the possibility of unspecific binding, the formation of the TAMRA-
RGD/integrin complex in buffer lacking divalent ions was monitored. No formation 
of TAMRA-RGD/integrin complex (Figure A13b) could be observed. Moreover, 
further addition of RGD 7 to this solution did not alter the anisotropy of the 
fluorophore solution. To assess the specificity of the binding, I performed a 
competitive binding assay between the WT LOV2 domain and the preformed TAMRA-
RGD/integrin complex, showing only a slight decrease in anisotropy upon protein 
addition (Figure A13c). This indicates specific recognition of the RGD motif by the 
integrin fragment. The formation of the TAMRA-RGD/integrin complex was 
completed after 45 min as shown by observation of the complexation kinetics. 
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Furthermore, the TAMRA-RGD/integrin complex was stable over 300 min, as shown 
by a constant anisotropy over this time interval (Figure A13a).  
 
 Competitive Binding Assay 
After determination of the needed integrin concentration to form the initial TAMRA-
RGD/integrin complex, competitive binding assays were performed. For this, LOV2-
RGD was successively added to the solution of TAMRA-RGD/integrin complex, which 
was preformed for 45 min. After an equilibration time of 30 min, the anisotropy of 
the solution was determined in dark and equilibrated in blue light for another 30 min 
before measurement. The obtained anisotropy curves were fit (Figure 5.5), and the 
amount of protein to displace 50 % of the integrin from the TAMRA-RGD/integrin 
complex was calculated (Equation 1-5). Three separate experiments per LOV2-RGD 
mutant were performed and the mean was calculated.  
 
Figure 5.5: Exemplary anisotropy curve of the competitive binding assay of RGD 7. Three independent 
experiments were performed, SD is displayed. Data points were fit to a Hill equation. 
In order to compute the final Kd values, the obtained values from the fit curves have 
to be adjusted to the competing equilibrium. Therefore, kinetic considerations have 
to be conducted, as shown below. 
 
 Calculation of the Dissociation Constant 
The obtained curves were fit with the Hill1 equation using Origin, assuming the 
starting value of anisotropy as a fixed starting point. From these fits the required 
concentration of LOV2-RGD mutant needed to replace half of the TAMRA-RGD 
fluorophore from the complex, was determined. For the first equilibrium between 
TAMRA-RGD/integrin and free integrin and free fluorophore, equation 1 is set: 
 
 
Equation 1:    
 
Equation 1 describes the equilibrium for TAMRA-RGD/integrin and can be solved by 
the following assumptions: Kd1 was derived from the curve fit (Figure 5.4b) and 
determined to be 15.48 nM ± 1.7 nM. In the equilibrium, the concentration of TAMRA-
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RGD/integrin was set (emanating from 20 nM fluorophore and 60 nM integrin 
fragment as starting concentrations) as 20 nM-x, the concentration of free integrin 
can be set as 40 nM+x, whereas x represents the amount of free fluorophore when 
the equilibrium is reached. With these values the amount of free fluorophore 
(TAMRA-RGDfree, x) was determined as 5.09 nM and the concentration of TAMRA-
RGD/integrin (20 nM - x) at the equilibrium is 14.92 nM. 
Upon addition of LOV2-RGD the equilibrium (equation 1) was shifted to a lower 
concentration of TAMRA-RGD/integrin complex. From the Hill1 fit the amount of 
protein required for displacing 50 % of the fluorophores from the integrin complex 
was determined for both conditions in dark and under blue light illumination, 
respectively. The equilibrium between TAMRA-RGD/integrin, TAMRA-RGDfree and 
Integrinfree was now shifted to only half of the concentration of the TAMRA-
RGD/integrin complex (7.46 nM), accompanied by an increased concentration of free 
fluorophores (12.54 nM) and Integrinfree (9.21 nM). 
 
To determine Kd2 of the competing reaction, the equilibrium between LOV2-
RGD/integrin and the free components is given with equation 2. 
 
 
 
Equation 2:   
 
Combining equations 1 and 2 allows to assess Kd2 with equation 3, taking both 
reactions into account, as shown in the following equilibrium: 
 
 
 
 
Equation 3:  
 
The concentration of LOV2-RGD/integrin can be assessed by assuming that the total 
amount of integrin equals the sum of all integrins either bound in complexes (with 
TAMRA-RGD or LOV2-RGD) or as free integrins (equation 4). 
 
Equation 4:  
 
With TAMRA-RGD/integrin = 7.46 nM, Integrintotal = 60 nM and Integrinfree = 9.21 nM, 
the concentration of LOV2-RGD/integrin complex was calculated to be 43.33 nM. The 
Kd2 LOV2-RGD/integrin
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concentration of free protein was similarly derived by the assumption shown in 
equation 5. Thereby, LOV2-RGDtotal represents the amount of protein required to 
replace 50 % of the fluorophores from the TAMRA-RGD/integrin complex and was 
given by Hill1 fit of the original curves. 
 
Equation 5:  
 
With the values for Kd1 = 15.48 nM, TAMRA-RGD/integrin = 7.46 nM, TAMRA-
RGDfree = 12.54 nM, LOV2-RGD/integrin = 43.33 nM and the values for LOV2-RGDfree 
extracted from equation 5; equation 4 can be solved for each LOV2-RGD mutant for 
the dark and lit states, respectively (Figure A14). 
 
 Ranking of Mutant Library 
After calculation of the Kd2 values, the protein mutants were ranked due to their 
capability to bind integrin in the lit state but not in dark. Therefore, the ratio of the 
Kd2,dark/Kd2,blue was used as a figure of merit for photoswitchability (Figure A14). The 
mutants were grouped into four categories. One group comprises the mutants with a 
Kd2,dark/Kd2,blue above 1.95 showing also a significant difference between the values in 
dark and blue (Figure 5.6).  
 
Figure 5.6: Kd2-values of the most promising LOV2-RGD mutants showing the highest difference in 
affinity to integrin between dark and lit state. SD displayed. Experiments were conducted in triplicates. 
Only the incorporation of the RGD motif at the beginning and at the end of the J!-
helix led to significant photoswitchablility. The affinity for integrin was almost 4.5-
fold higher under blue light than in dark for the RGD 7 mutant with one RGD motif 
integrated at the end of the helix, and 1.7-fold for the RGD 1 mutant (Figure 5.7a). 
The introduction of helix stabilizing mutations did not, or only neglectably led to an 
increased caging of the RGD in the dark state. For mutant RGD 7 the stabilization led 
to an even significantly decreased dissociation constant in the dark, meaning 
enhanced binding in the dark, in comparison to the original mutant. 
Combining several RGD motifs in one RGD mutant led to increased binding affinity of 
the mutant to integrin and therefore to a smaller dissociation constant in dark and 
under blue light. This could be monitored for all combinations of RGD motifs 
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independent from the position of the motifs. Nevertheless, some RGD motif positions 
exhibited a higher binding affinity than others, no matter if they were introduced 
alone or in combination with other motifs (RGD 1 vs RGD 2, Figure 5.7). The most 
promising mutants with multiple RGD motifs is RGD 77 with two consecutive RGD 
motifs at the end of the helix (exhibiting a 2.6-fold increased affinity to integrin 
under blue light illumination than in dark), and the combination of RGD 7 with RGD 1, 
yielding RGD 177 with a 1.9-fold affinity increase. 
The effect of the incorporation of the PHSRN motif is highly dependent on the 
position of the RGD motif. Introduction of PHSRNi (PHi) (in the "-sheet loop, close to 
the end of the J!-helix (Figure 5.2a), led to an increased binding affinity when 
combined with RGD motifs at the end of the helix, like PHi 7, PHi 77 and PHi 4s, but 
not when combined with motifs at the beginning of the helix like PHi 1s and PHi 2s. 
However, the Kd2,dark/Kd2,blue ratio was not increased upon PHSRNi introduction. The 
insertion of PHSRNiii (PHiii) (immediately before the J!-helix) did only exhibit any 
increase in the binding affinities or on the Kd2,dark/Kd2,blue ratio, therefore this set of 
mutants was discarded and not further taken into account for cell adhesion studies. 
Incorporation of the PHSRNii (PHii) motif at the N-terminus of the J!-helix did not 
result in a significant increase in the binding affinity of the LOV2-RGD mutants, 
nevertheless a reasonable Kd2,dark/Kd2,blue ratio is preserved for PHii mutants combined 
with RGD motifs at the end of the helix (PHii 7, PHii 77). Because the synergistic effect 
of PHSRN may only be significant when integrins are engaged in FA, these mutants 
were further tested in cell adhesion experiments.14 
The incorporation of the surrounding amino acids of the RGD from cellular 
fibronectin led to a major enhancement in binding affinity of integrin to the RGD 7c 
mutant in comparison to RGD 7, while a 2-fold increase in integrin affinity under blue 
light is preserved. Since also other integrin types than !#"3 are involved in cell-
matrix adhesion, which are exhibiting different kinetics and binding affinities to 
cellular FN, the trends found in in vitro studies do not necessarily reproduce the 
trends in cell-matrix adhesion,15,20,178-180 and need to be tested in cell adhesion 
experiments. 
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Figure 5.7: Kd2-values grouped according to their dark state affinity in a) good binders with a 
Kd2 < 800 nM, and b) medium binders Kd2 <1000 nM and >800 nM. SD displayed. c) Group of non 
binders exhibiting a Kd2-value above 1000 nM. 
Besides the LOV2-RGD mutants exhibiting a Kd2,dark/Kd2,blue above 1.95 the mutants 
were sorted regarding their binding affinity in dark. For the group of good binders 
all mutants exhibiting a dark state binding affinity below 800 nM were chosen. For 
the group of medium good binders, a limit of the Kd2,dark of below 1000 nM was chosen. 
Some design strategies did not lead to significant binding of integrin. These mutants, 
exhibited a dark state dissociation constant above 2000 nM and a Kd2,dark/Kd2,blue ratio 
< 1.66. These were categorized as “non-binders” and not further used in cell adhesion 
studies (Figure 5.7c). As a positive control cRGD was used, showing a Kd2,dark of 
54 nM ± 2.8 nM (Figure A13d). 
With our protein design strategies, a library of 40 mutants representing different 
dynamic range in the affinity to integrin could be obtained. The dynamic range in 
binding affinity of other LOV2 based systems varies broadly depending on the 
introduced effector,150,154 additional mutations151 in the protein domain and the 
experimental setup the photo-switch is used in,181 and need to be adapted or chosen 
in regard of the dynamic range of the modulated process. 
From the 40 mutants of the LOV2-RGD library, eight mutants (Figure 5.6) were 
selected showing the highest photoswitchability (Figure A14) and further 
characterized in cell adhesion studies.  
5.4 Cell-Matrix Adhesion Studies 
In order to assess the ability of the most promising LOV2-RGD mutants derived from 
the fluorescence anisotropy measurements, the mutants were employed in cell 
adhesion studies. To determine whether the employed light intensities negatively 
affect the cell metabolism, a colorimetric metabolic activity assay was performed. 
Therefore, the cell induced reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
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dephenyltetrazolium bromide (MTT) dye to a formazan derivative was studied by 
absorption measurement of the product at 540 nm after 4 hours incubation with the 
cells. Reduced absorption indicates a reduced metabolic activity and thereby an 
influence of the employed light on the cells. The metabolic activity of U-2 OS cells 
was determined in dependence of different light intensities (Figure 5.8).  
 
Figure 5.8: Colorimetric metabolic activity assay to determine phototoxic effects of blue light in different 
intensities on U-2 OS cells. No significant change in the metabolic activity could be observed in all light 
intensities in compared to samples kept in dark. 
The absorption at 540 nm is the same within the error bars under all employed light 
intensities and in dark (Figure 5.8). This concludes that light of the wavelength of 
471 nm does not have phototoxic effects on the metabolic activity of the cells. In 
order to employ enough intensity to sufficiently reach the switching equilibrium of 
the LOV2-RGD mutants, light of 471 nm at an intensity of 12.5 µM/m2s was used for 
all further cell adhesion studies. Higher intensities may not affect the metabolism of 
U-2 OS cells, but since the system should be employable to less robust cell types,182 or 
primary cells,183 t higher intensities are avoided.184  
5.4.1 Cells can Adhere to Surfaces Modified with LOV2-RGD 
Mutants 
Before investigating the ability of LOV2-RGD mutants to reversibly switch cell-
surface adhesion, the ability to mediate cell adhesion was assessed. Therefore, glass 
surfaces were coated with a self-assembled monolayer (SAM) of PEGazide and further 
functionalized with copper mediated click-reaction with NTA-alkyne. The NTA 
groups were charged with Ni2+ and the respective protein mutant was subsequently 
immobilized. 5000 cells/cm2 were seeded in serum free medium onto the protein 
functionalized surfaces and incubated in dark or under 12.5 µM/m2s blue light 
illumination for 2 hours. After fixation, the actin network was stained with 
phalloidin-Tritc to observe whether cell spreading has occurred and the nucleus with 
dapi, which allowed to assess the number of adherent cells on 1 cm2 (Figure 5.9). Non-
adherent cells were washed away during the staining process. 
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Figure 5.9: Number of adherent cells on surfaces coated with the respective LOV2-RGD mutants in dark 
or under 12.5 !M/m2s blue light illumination. Surfaces coated with LOV2 as well as the PEG passivated 
surface (PEG) served as negative controls, whereas surfaces coated with cRGD were taken as positive 
control. No difference in the cell number between the lit state and the dark state could be found, but 
trends found in the fluorescence anisotropy experiments could be confirmed. Multiple RGD motifs 
increased the integrin binding capability of the surfaces compared to surfaces with single mutants. Also 
the incorporation of the context amino acids found in cFN led to increased cell adhesion. Experiments 
were conducted in triplicates and the error bars represent the SD. 
The LOV2-RGD mutants are able to mediate cell adhesion to different degrees. The 
trends found in the fluorescence anisotropy characterization could be reproduced. 
Mutants showing only low binding to the integrin fragments in the fluorescence 
anisotropy measurements, exhibited a higher dissociation constant (Kd2) and also less 
cells could adhere to the respectively modified surfaces. The trend of increased 
affinity to integrin by introduction of multiple RGD motifs was also confirmed in the 
cell adhesion study. A single RGD motif was not enough to mediate proper cell 
adhesion. The number of cells on surfaces functionalized with RGD 77 was higher 
than on surfaces with RGD 7 and RGD 177 showed the highest number of adherent 
cells. Almost as many cells adhered to surfaces coated with RGD 177 than to the 
positive control cRGD. As negative controls PEG covered surface itself or 
functionalized with the WT LOV2 was utilized, showing almost no adherent cells 
(Figure 5.9). Only few cells could attach to surfaces functionalized with the LOV2 
domain; however, no spreading occurred, indicating that the adhesion mediated by 
the LOV2-RGD mutants is specific recognition of the RGD motif by the cellular 
integrins. The six-fold increase in affinity to integrin for RGD 7 received from the 
anisotropy fluorescence experiments could not be reproduced in cell adhesion 
experiments. The caging of the RGD motif in solution was more efficient than if cells 
adhere actively to the LOV2-RGD 7 protein. As afore mentioned also other families of 
integrin are involved in cell-matrix adhesion and contribute to the binding of to the 
RGD motif. Integrins like !5"1 are binding exclusively FN and exhibit different 
dynamics and affinities to the RGD-motif, which cannot be compared to the in vitro 
studies with isolated !#"3.185 
 
The incorporation of the PHSRN motifs had a significant effect on cell adhesion and 
the response to blue light. When RGD 7 was combined with PHi or PHii, cells adhered 
more efficiently to these surfaces than to surfaces with mutants without the synergy 
peptide. Additionally, the cells spread better under blue light than in dark, and in 
comparison to RGD 7. The improved spreading under blue light was according to the 
initial design. In dark the PHSRN motifs are spatially close to the RGD 7 motif (< 5 Å), 
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whereas under blue light the helix unwound and the optimal distance between the 
PHSRN motif and the RGD motif was achieved. The PHSRN motifs (PHi, PHii) are in 
close proximity to each other but exhibit different effects when combined with 
RGD 7. However, the combination of the PHi motif (in the loop of the "-sheet, Figure 
5.2a) with the RGD 7 at the end of the helix resulted in increased cell numbers on the 
respective surfaces, the combination with the PHii motif (which is located at the N-
terminus, so in close proximity to the PHi motif) did not improve cell adhesion 
compared to the RGD 7 mutant. Similar effects can be observed with the 
combinations of the respective PHSRN motifs and the RGD 77 mutants. The 
combinations of the particular PHSRN motifs and the mutant RGD 1s did not lead to 
higher cell numbers on the respective surfaces (Figure A15). 
The introduction of the amino acid context of RGD found in cellular fibronectin led 
to an increase in the number of adherent cells in comparison the RGD 7, confirming 
trends already found in literature.173 Since integrin mediated cell-matrix adhesion is 
a complex process, many other aspects can influence cell-matrix adhesion. Not only 
other integrins are involved in adhesion to the RGD motif and the PHSRN motif, the 
cells can also apply force, which activates and strengthens the integrins bonds.186 By 
the application of force it is also conceivable that the cells will model the synthetic 
FN, LOV2-RGD.187,188 
 
Not only the number of adherent cells is an aspect in cell-matrix adhesion, but also 
the adhesion area of the spread cells. Proper cell adhesion leads to cell spreading, 
which is a prerequisite for cell performance. If the cell can find enough adhesion 
points, it will spread and explore the given environment. If the cells cannot 
sufficiently establish cell-matrix contacts, they retain their spherical shape with only 
little contact to the surface. Upon spreading the cell flattens to a fried-egg 
morphology and form FA. The actin staining was used to evaluate the spreading area 
of the cells on the different LOV2-RGD mutants. The adhesion area of 70 cells was 
determined, and the distribution of the spreading area on the respective surfaces was 
analyzed and displayed in a frequency plot. Figure 5.10 depicts examples of the 
spreading area of cells interacting with surfaces functionalized with RGD 177 in dark 
and under blue light illumination, respectively. As a positive control cells on surfaces 
covered with cRGD are shown. 
Photo-Switchable Cell Adhesion 
!&-!
 
Figure 5.10: Exemplary images of cells adhered to surfaces coated with RGD 177 either incubated in the 
dark or under blue light illumination. Cells on cRGD functionalized surfaces are shown as a positive 
control. In the merged image, actin is displayed in red and the nucleus is displayed in blue. Scale bar 
100 !m. 
The frequency analysis (Figure 5.11a) of the distribution of the spreading area on 
RGD 177 surfaces, showed a shift to larger areas on blue light illuminated samples 
compared to cells grown in the dark. Cells adhered to the lit state surfaces exhibited 
two different fractions, one fraction with spreading areas around 200 µm2, similar to 
the dark state, and a second fraction with a broader distribution peaking around 
320 µm2. It can be assumed that the first fraction are cells, which found only few 
adhesion spots to attach to the surface, but not enough for sufficient spreading, 
similar to the dark state surfaces. Whereas the second fraction of cells were able to 
form enough adhesion contacts to effectively spread (Figure A16).  
 
Figure 5.11b depicts the spreading areas as box plots determined on surfaces kept in 
dark or under blue light illumination for each mutant, respectively. As afore 
mentioned, the median spreading area on several LOV2-RGD mutants exhibited 
differences between samples kept in dark or under blue light illumination. The most 
promising candidates were RGD 77, RGD 177, RGD 7c, PHi 7 and PHii 7, since they 
exhibited a significant difference between the spreading area of cells on dark samples 
compared to lit samples. The mutants RGD 177 and PHi 7 show a difference of about 
60 µm2 difference in the median spreading area, indicating a stronger adhesion under 
blue light. PHii 7 only exhibit a difference of about 40 µm2, showing a decreased 
adhesion within the timescales compared to the aforementioned protein mutants 
under blue light illumination. Interestingly RGD 7c showed a higher spreading area 
on the dark state samples. As aforementioned, cRGD exhibits a higher affinity to 
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integrin than the natural ligand, which is attributed to the relative orientation of the 
amino acids to each other in the cyclic orientation.78 Suggesting that in the dark state 
RGD 7c exhibits a helical conformation of the GRGDSP motif, it may be a preferred 
conformation for integrin adhesion in the dark (pseudo cyclic) than in the lit, 
disordered, state, which favors the adhesion of integrin. 
 
Figure 5.11: Spreading area analysis of cells incubated on surfaces functionalized with the respective 
protein mutant, in dark or under blue light illumination. a) Frequency plot of cells spread on LOV2-RGD 
177 functionalized surfaces in dark (black) or in lit state, showing two populations in the lit state (blue). 
The spreading area of the first population peaks at 200 !m2 , whereas the spreading area of the second 
population peaks at 320 !m2 b) Spreading area of cells incubated on the respective surfaces in the dark 
or under blue light illumination. Experiments were conducted in triplicates, cell number analyzed: 
n > 500, 10 - 90 % confidence interval is shown. 
5.4.2 Formation of Focal Adhesions in Dependence of LOV2-RGD 
Mutants 
In order to investigate the formation of focal adhesions on the different surfaces, FA 
proteins were visualized by immunofluorescence. To visualize the formation of FAs, 
vinculin was targeted as it is recruited at an early time point of the focal adhesion. 
To verify the tension-mediated maturation of the focal adhesion, the late time point 
FA protein zyxin was chosen. Zyxin is recruited to actin stress fibers with increasing 
forces applied from the cell to the surface.38,189 In the magnification of the FAs, it can 
be observed that zyxin is recruited to the tip of the FA, whereas vinculin is present 
in the complete FA. Mature FA can be found on surfaces coated with the respective 
protein mutants independently of the state (light or dark) of the respective protein 
mutants (Figure 5.12). Differences in shape and polarization of the cells (Figure 5.12) 
are caused by the selection of images and do not show any trend based on the 
respective protein mutant or illumination state.  
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Figure 5.12: Immunofluorescence of focal adhesion proteins in cells, cultured on the different indicated 
surfaces. In the merged image, zyxin is displayed in green, vinculin is displayed in red, actin is displayed 
in grey and the nucleus is displayed in blue. No difference in the formation of focal adhesions between 
the dark and the lit state could be observed. Scale bar 20 !m, panel length: 20 !m. 
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In cell adhesion experiments five mutants were found, which mediated proper cell 
adhesion and changes cell adhesion in response to blue light. These mutants cover a 
range of adhesiveness and switchability. The most promising designs were RGD 177, 
PHi 7, PHii 7, RGD 77 and RGD 7c. After the capability of the LOV2-RGD mutants to 
mediate different degrees of cell adhesion depending on the protein state was 
assessed in cell adhesion experiments, the reversibility of these systems needed to be 
verified.  
5.4.3 Reversible Switching of Cell Adhesion 
To determine the reversibility of cell adhesion on surfaces functionalized with the 
LOV2-RGD mutant, cells were seeded on surfaces functionalized with the respective 
protein mutant. To compare the change in the spreading area upon switching the 
protein surface to the less adhesive, dark state, surfaces were either kept under blue 
light illumination for 3 h, kept in dark for 3 h or were switched from the illuminated 
state to the dark state after two hours.  
Subsequently, the spreading area based on the actin staining was analyzed. Cell 
adhesion could only be switched effectively on surfaces functionalized with the 
mutants RGD 77 and PHii 7 (Figure 5.13).  
 
Figure 5.13: Reversion of the spreading area of cells cultured for 3 h on the respective protein surfaces 
in either dark (grey box), lit (blue box) or switched to dark after 2 h blue light illumination (red box). 
The experiments were conducted in three technical repeats, cell number analyzed: n > 140. 10 % - 90 % 
confidence interval is shown. 
The surfaces functionalized with RGD 77 were successfully switched resulting in a 
decreased spreading area of 310 µm2 (Figure 5.14a). Since the cells on surfaces kept 
in the lit state exhibited a spreading area of 360 µm2, the spreading area decreased 
about 14 % when the illumination was stopped. The spreading area of cells on 
surfaces kept in dark do not differ from the spreading area on the switched sample, 
indicating a full reversion to the dark state within one hour. Similar results were 
obtained for PHii 7 (Figure 5.13b). However, the average spreading area did not 
completely but partially switch back to areas obtained in the dark state. This 
indicates a different adhesion kinetic on surfaces functionalized with PHii 7, which 
was expected since the PHSRN motif is an additional adhesion motif and will 
positively render the mode of integrin adhesion to the RGD motif.  
Noticeable is also the variance of the average spreading area on both samples. Cells 
on surfaces coated with RGD 77 have a distribution of about 150 µm2 (25 % - 75 % 
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confidence interval), independent of the illumination state. Cells on surfaces coated 
with PHii 7 have a variance in the dark of about 100 µm2 but almost double on lit state 
surfaces. This indicates that the cells start to spread more on illuminated samples. 
Cells on reversed surfaces exhibit a variance of about 120 µm2, showing a partial 
reversion in the spreading areas when illumination is stopped. For the other mutants, 
no reversion could be observed (Figure A17). Cell adhesion was reversible on surfaces 
where cells adhered but spread less (RHD 77 and PHii 7) in comparison to surfaces 
where cells adhered and spread extensively (RGD 177, PHi 7, RGD 7c). Potentially, this 
is caused by strong binding of integrin to the RGD which prevents the refolding of 
the J!-helix in the dark and thereby reversion. Thus, LOV2-RGD mutants exhibiting 
a weaker binding to RGD can undergo reversible conformational changes when the 
integrin dissociates from the J!-helix. 
To verify the reduced average spreading area on samples kept in dark, cell-surface 
interactions of living cells were monitored during the dark state induced detachment 
process using the (interference reflection microscopy) IRM setup. In the IRM setup 
the proximity of the sample to the surface is assessed, allowing an estimation of the 
spreading area of each cell. Additionally it is noninvasively, can be used without pre 
staining of the cells and was used at longer wavelength (632 nm) to avoid 
unintentional activation of the LOV2-RGD mutants. 
U-2 OS cells were seeded on protein functionalized surfaces and incubated in serum 
free medium under blue light illumination for two hours to allow adequate cell-
matrix adhesion. Afterwards the surfaces were transferred to the microscope and 
further monitored in the IRM mode in either dark or under blue light illumination 
for three additional hours. The experiments were conducted in duplicates, averaging 
the spreading area of at least 70 cells per condition and error was displayed as SEM.  
Integrin mediated cell-matrix adhesion could be reversibly switched for both 
mutants in dark. When the cells were subsequently incubated in dark, the average 
spreading area decreased on both LOV2-RGD mutants. Cells cultured on surfaces 
coated with RGD 77 showed a decrease in spreading area to 86 % but cells cultured 
under blue light on the respective surfaces increased in spreading area to 110 % 
exhibiting a difference in spreading area of 24 % (Figure 5.14a). Since the intial 
average spreading area on samples which were monitored in dark in IRM was bigger 
compared to the samples monitored in IRM under blue light, the total average 
spreading area after three hours in the respective lit state, does not show the 
reversion as the normalized average spreading area (Figure 5.14a). Note that also in 
the live cell reversiblity experiments, the variance of the average spreading area on 
surfaces coated with RGD 77 is constant, confirming the observation of the previous 
reversibility experiments. 
The spreading area of cells adherent to surfaces coated with PHii 7 in dark, decreased 
to 86 %. In comparison, cells cultured on the same surfaces under blue light 
illumination increased their average spreading area to 136 %. This results in a 50 % 
difference in the spreading area of cells between the dark and lit state of LOV2-RGD 
coated surfaces (Figure 5.14b). The average spreading area of cells on lit state surfaces 
is 208 µm2, whereas cells on surfaces kept in dark only, exhibit a average spreading 
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area of 81 µm2. In Figure 5.14c a cell monitored via IRM in dark on a PHii 7 coated 
surface for three hours is shown exemplarly.  
 
Figure 5.14: Live cell experiments with cells cultured on surfaces functionalized with RGD 77 or PHii 7. 
First column: Reversion of normalized spreading area of cells on surfaces kept in dark or as a positive 
control under blue light illumination, after 2 hours blue light preincubation. n = 70 cells, two 
independent experiments, SEM displayed. Second column: Plot of the not normalized final spreading 
area between the dark and lit state, 10 – 90 % percentile displayed. a) on surfaces with RGD 77, b) on 
surfaces with PHii 7. c) Retracting cells on a PHii 7 functionalized surface kept in dark in IRM over the 
time scale of 3 hours. Scale bar: 15 !m. 
Cell-matrix adhesion is not a linear process but can be grouped into three phases. If 
cells are added to an adhesive surface, they first sedimentate on the surface, forming 
initial electrostatic interactions. In the second phase initial integrin contacts and 
nascent FA are formed, strengthening the contact to the underlying substrate and 
giving the cell a flattened shape. In the third phase, the FA mature, the cells reach 
the full spreading and the intracellular actin network is formed (e.g. formation of 
stress fibres). In this phase the cell is able to apply forces to the surface remodel the 
ECM, polarize and migrate.190,191 Since RGD 77 and PHii 7 present different adhesion 
motifs, it is hypothesized that the cells also exhibit different adhesion kinetics on the 
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respective surfaces, which consequently alters the speed the cells enter into the 
repsective adhesion phases.  
These changes in cell adhesion area have high impact on cell behaviour, since already 
small changes can lead to altered gene expression100 or even stem cell differentiation 
into different cell lines.107 
Notably, the reversion of cell adhesion is relatively slow and not completed even after 
three hours, in contrast to the half-life times of the protein recovery itself (Figure 
5.3). This can be ascripted to the tight binding of integrin to the RGD motif. If integrin 
is docked to RGD the binding most probably outperforms the switching of the 
protein, making the integrin recycling and focal adhesion turnover the rate limiting 
step.41 Additionally, the cells apply forces on the proteins, which possible impede the 
refolding of the J!-helix. To further characterize if the integrin binding alters the 
switching dynamics of the proteins itself, a reversibility assay with fluorescence 
anisotropy was performed. 
5.5 In Vitro Characterization of Reversible Integrin 
Binding of LOV2-RGD Mutants  
In oder to monitor the switching of the protein in vitro, I performed an anisotropy 
assay to see if the binding of LOV2-RGD mutants to TAMRA-RGD can be reversed. 
After formation of TAMRA-RGD/integrin complex, the protein concentration yielded 
from the initial titration (see chapter 5.3.2) was added to the solution and incubated 
for 90 min. Subsequently the solution was illuminated with blue light for 15 min and 
the anisotropy was measured, followed by a 30 min relaxation time in dark prior to 
an additional measurement. The reversion monitored in fluorescence anisotropy of 
the lit state LOV2-RGD/integrin complex to the equilibrium in dark was already 
achieved after several minutes as shown in the kinetic estimations (Figure 5.15 a) for 
RGD 77 and b) PHii 7, respectively). For PHii 7, the reversion time was 10 min, as 
indicated with the dashed line (Figure 5.15b). 
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Figure 5.15: In vitro reversibility assessed with competitive fluorescence anisotropy binding assay. First 
column: Dark reversion kinetics. Second column: reversible switching for three times after an initial 
incubation time of 60 min under blue light illumination. a) For mutant RGD 77 and b) for mutant PHii 
7, showing a switching kinetic of 10 min. Experiments conducted in quadruplicates, SD displayed. 
The general trend of decreasing anisotropy values for RGD 77 (Figure 5.15a) is 
possibly due to incomplete complex formation but will be further investigated. 
Nevertheless, a reversion for both mutants from the less binding (dark) state to the 
improved binding (lit) state, triggered by illumination can be observed. The 
difference in the anisotropy was smaller for RGD 77, indicating a less complete caging 
of the RGD motifs in dark, as already observed in cell adhesion experiments (Figure 
5.9). For PHii 7 the switching was more significant (Figure 5.15b).  
 
With the herein presented approach of rationally designing a mutant library and 
selection of the suitable mutants with the combination of in vitro and in cellulo 
experiments, two LOV2-RGD mutants were chosen to reversibly switch cell adhesion 
with blue light. 
0 10 20 30 40 50
55
60
65
70
Time [min]
A
ni
so
tro
py
RGD 77
0 10 20 30 40 50
55
60
65
70
Time [min]
A
ni
so
tro
py
PHii 7
a)
b)
50 75 100 125 150 175 200
45
50
55
60
Time [min]
A
ni
so
tro
py
50 75 100 125 150 175 200
55
60
65
70
75
Time [min]
A
ni
so
tro
py
 !
  
 !
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
III. Conclusion and Outlook 
 !
 ! '$!
6. Substrates for Photo-Cleavable Cell-
Surface Adhesion 
 
Adhesion of cells to the ECM is an important factor in many cellular processes, like 
wound healing and embryogenesis and is tightly regulated in time and space. 
Therefore, the development of platforms that can effectively control cell adhesion to 
manipulate these processes are of great interest. Light is often preferred to 
dynamically regulate the ability of substrates to mediate cell-matrix adhesions, since 
light is the only stimulus providing both a high spatial and temporal resolution, 
predestining it for the application in tissue engineering. Additionally, light allows to 
tune interactions by changing illumination time or frequency, can be employed in a 
dynamic manner and different processes can be addressed with different 
wavelengths. Light-regulated substrates for cell-matrix adhesions often employ UV-
light, bearing the risk of phototoxicity by generation of reactive oxygen species. 
Therefore, systems responding to light of longer wavelength need to be engineered. 
The combination of optogenetic building blocks responding to longer wavelengths 
and tissue engineering creates a feasible tool for studying cell-surface interactions 
using visible light. In this work, I effectively combined optogenetic proteins with 
material science to control cell adhesion with green light based on CarH, a green 
light-cleavable protein derived from T. thermophilus. The here employed protein 
CarH, originally functions as a gene repressor, which assembles upon interaction 
with the cofactor vitamin B12 into a tetramer, and is disassembled upon green light 
illumination ($ = 523 nm). I successfully modified the protein monomer sequence by 
introducing the RGD motif at four different positions, as well as its surrounding 
amino acids in cellular fibronectin. Since the RGD motif is a versatile ligand for many 
integrins, the system can be employed for a variety of different cell types, without 
the need of invasive manipulations of the cells. The protein can be recombinantly 
expressed in E. coli in large amounts, preventing tedious and costly preparations of 
chemically synthesized building blocks. The protein expression was quantified with 
SDS PAGE and the protein tetramer assembly upon cofactor addition was visualized 
by indirect immunofluorescence. I showed by UV/Vis spectroscopy that the 
monomer assembles into the respective tetramer and disassembles upon green light 
illumination. The tetramer could be immobilized on NTA-coated surfaces via the His-
tags as confirmed with QCM-D experiments. By incubation of integrin !#"3 on the 
tetramer coated QCM-D crystals, the frequency shifted, indicating a successful 
binding of integrin to the RGD motif of CarH. Upon green light illumination, the 
tetramer disassembled and the integrin/protein complex successfully detached from 
the crystal. In samples kept in dark, the frequency did not shift, indicating that the 
tetramer was stable in the dark. 
After the CarH-mutants were successfully generated and characterized on their 
ability to attach to surfaces as well as to bind integrin, the most promising candidate 
was further tested in cell adhesion experiments. I showed that in the dark, when the 
protein is a tetramer, the protein-coated surfaces mediate cell adhesion. After green 
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light illumination, the CarH tetramer disassembled and the number of adherent cells 
decreased. Approximately 2.5-fold more cells adhered to surfaces kept in dark 
compared to the illuminated sample. Moreover, the median spreading area 
determined on the dark samples was 13 % larger than on the illuminated samples, 
confirming the trend of improved cell adhesion and spreading to substrates 
functionalized with the tetrameric form of the protein. 
In this thesis, I engineered a surface, which is switchable with green light from an 
adhesive dark state to a less adhesive lit state. I characterized the protein 
characteristics with QCM-D, UV/Vis spectroscopy and indirect immunofluorescence 
staining. In cell-adhesion experiments I showed that cells can adhere to the dark state 
but not to the lit, decomposed state of the protein. With this system, I demonstrated 
for the first time that cells can be effectively captured and released by utilizing green 
light as a stimulus for direct manipulation of ligand presentation. 
Drawbacks of this systems are that the CarH is sensitive to very little intensities of 
ambient light. Therefore, the experiments need to be performed exclusively under 
red light or in the dark, which is not so convenient for the experimental setup.  
7. Substrates for Reversible Cell-Surface 
Adhesion 
 
One of the remaining challenges in controlling cell-matrix adhesions is to control 
them reversibly. In order to generate a reversibly switchable surface for cell-matrix 
adhesion, I designed a protein library based on the blue light-switchable LOV2 
domain. Therefore, I successfully incorporated the RGD and the synergy peptide 
PHSRN from cellular fibronectin in various positions within the LOV2 domain. The 
LOV2 protein domain is a blue light photoreceptor that undergoes a huge 
conformational change upon blue light illumination, resulting in the unfolding of an 
C-terminal helix. Thereby, amino acid sequences hidden within the helix, are 
exposed. The RGD and the PHSRN motif were chosen because they are versatile 
ligands of many integrins and can be employed to trigger adhesion in a variety of cell 
lines. The PHSRN motif has a synergistic effect on the affinity of integrin to the RGD 
motif, which is depending on the distance between both motifs. In cellular 
fibronectin, the motifs are 35 Å apart, which is matching the length of the LOV2 
domain (31 Å). Since LOV2 undergoes a conformational change, the distance increase 
was used to enhance the binding affinity of integrin to the RGD motif in the unfolded 
state of the protein. In dark, the LOV2 domain thermally relaxes within minutes into 
the dark state and refolds its helix, such that the RGD motif is hidden again. 
Therefore, the designed proteins allow a blue light induced reversible RGD exposure. 
A library of 40 LOV2-RGD mutants was successfully designed, expressed and purified 
in high yields. To assess the mutants’ affinity to integrin in dark and under blue light 
illumination, I established an in vitro fluorescence anisotropy assay. For this, I 
determined the binding affinity of integrin !#"3 to a TAMRA labeled RGD and 
performed a competitive binding assay with the mutant library to quantify Kd values. 
 ! '&!
The library of LOV2-RGD mutants was ranked based on the change in Kd under blue 
light compared to the dark and on the ability to bind integrin. I showed that the 
increase in the number of RGD motifs in a mutant and the incorporation of the 
context amino acids of the RGD motif as found in cellular fibronectin led to a smaller 
dissociation constant. However, only little change in Kd could be seen upon the 
insertion of the PHSRN motif or stabilizing amino acids. The protein mutants showing 
the highest Kd2,dark/Kd2,blue ratio were selected for cell adhesion studies.  
In cell adhesion experiments, the number of adherent cells on surfaces coated with 
the respective LOV2 mutant was assessed in the dark and under blue light. While the 
number of cell on the surfaces did not change for surfaces kept in dark or illuminated 
with blue light, the cell spreading area significantly changed. The spreading area on 
samples illuminated with blue light was larger than on samples kept in dark for 
almost all protein mutants. Trends in the cell number on the respective surfaces 
resembled the trends already obtained from the fluorescence anisotropy 
measurements, thus validating the experimental setup in cellulo. To assess if the cells 
could form FA, the FA proteins vinculin and zyxin were detected by indirect 
immunofluorescence staining in a reduced mutant library. I showed that cells can 
form mature focal adhesions on surfaces with the respective protein mutants in dark 
and also under blue light illumination. To further characterize the reversibility of the 
system, I performed switchable cell adhesion experiments. By comparing the median 
spreading area on surfaces switched from the lit to the dark state, and samples 
constantly kept in dark or light, I could demonstrate that only cells adhering to 
surfaces functionalized with PHii 7 or RGD 77 showed photo-induced reversion in the 
spreading area. In order to avoid unwanted photo-activation of the protein, I used 
IRM at longer wavelengths to label free monitor changes in cell-surface interactions. 
I could show that the spreading area decreased when the samples were monitored in 
dark, but increased when the surfaces were kept under blue light. Since the timescale 
for cell detachment is long in comparison with the protein switching (which occurs 
within minutes), I concluded that the rate limiting step is not the switching of the 
protein, but the turn-over of the integrins, which mediate the cell adhesion.  
Herein, I designed and developed a reversible blue light switchable system which can 
be utilized to switch cell-matrix adhesion by adressing the natural adhesion proteins, 
integrins. The blue light did not show any photo-toxic effects on the cells and 
potentially toxic wavelengths as UV-light were avoided. Additionally, the building 
block is recombinantly expressed, not cell-toxic and facile to purify in high amounts. 
Since the LOV2 domain is intrinsically reversibly switchable, surfaces coated with the 
introduced mutants dynamically modulate cell-matrix adhesion.  
 
To further impove the here presented systems, either the optogenetic proteins 
themselves can be improved, or the presentation of the proteins to the cells can be 
modulated. For the LOV2-RGD mutants, the dynamic range of the two mutants 
employed in cell experiments was only small and could be further improved by 
insertion of specific mutations. As already described in the introduction, the dynamic 
range of the oLID system for example was improved from an initially 8-fold difference 
between the illumination states to a 59-fold difference for iLID/Micro.150 This was 
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achieved by an integrated approach of computational design, phage display and high-
throughput binding assays. During this process, Guntas et al. considered 743 
mutations and 49 positions closely located to the J!-helix, to identify several single 
mutations, which led to this enormous increase in binding affinity. Following a 
similar approach for my optogenetic setup could lead to a larger dynamic range of 
the respective LOV2-RGD mutants, and therefore, to a higher significance in cell 
behavior on the lit state surfaces in comparison to the dark state surfaces. Regarding 
the CarH-RGD mutant, the accessibility of the RGD motif needs to be enhanced, to 
improve cell spreading. This can be achieved by incorporation of a linker between 
the RGD motifs and the protein core. Further, additional binding motifs like the 
PHSRN motif can be inserted to gain a higher ligand density on the surfaces.  
For LOV2-RGD controlled cell-matrix adhesion, not only the ligand presentation of 
the RGD motif itself is a factor, also ligand density on the surface plays an important 
role for cell adhesion. In this work the surfaces had always been functionalized with 
100 % protein, thus the RGD density was only determined by the the number and 
accessibility of the incorporated RGD motif.15,192 Since the LOV2 domain has a 
diameter of 3 nm, the surfaces present sufficient adhesion motifs for cell spreading. 
If the ligand density is shifted to hight distances, thus providing enough anchoring 
points for cells in the illuminated state, reversion to the dark state could switch the 
surface “off” and prevent cell adhesion. Altering the ligand density can be achieved 
by changing the amount of functionalizable groups immobilized on the surface. Here, 
I demonstrate preliminary data of a proof of principle experiments, where surfaces 
were modified with different percentages of clickable PEGazide, leading to a lower 
LOV2-RGD mutant coverage. The number of cells adhering to surfaces of different 
RGD 177 densities in the dark was analyzed (Figure 5.16). Reducing the ligand density 
from the previously shown 100 % coverage to 35 %, (dashed line in Figure 5.16) at the 
inflection point, modulated the light-driven effect of ligand accessibility. The 
inflection point of the graph varies for each LOV2-RGD mutant, which is further 
characterized in ongoing studies.  
 
 
Figure 5.16: Characterization of the influence of LOV2 mutant density on cell number. Shown are 
surfaces functionalized with RGD 177 in dark, featuring the point of inflection at 35 % surface coverage, 
as an optimized protein density for this RGD mutant. 
However, the here presented reversible switchable system can already be applied to 
investigate cellular processes, like the formation and turnover of FA in a time 
controlled manner. Since the system is applicable within the time scale of cell-matrix 
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adhesion and biological processes dependent on cell-matrix adhesion such as 
directed migration or stem cell differentiation can be investigated in a dynamic 
manner with high spatiotemporal resolution, which was not possible with the 
previous systems. 
The green-light switchable system can be used to capture and release cells with the 
speed of light and could be further used to investigate cellular responses to sudden 
loss of ECM contact or to investigate reorganization of the actin cytoskeleton upon 
partial disassembly of the adhesion sites. 
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 !
 
 
 
 
 
 
 
 
IV. Materials and Methods 
 !
 ! (+!
8. Materials 
 
8.1 Chemicals and Reagents 
25 % (v/v) Ammonia Merck, Darmstadt, Germany  
4',6-diamidino-2-phenylindole, DAPI Merck, Darmstadt, Germany 
Agarose Carl Roth, Karlsruhe, Germany 
Agarose for DNA Serva, Heidelberg, Germany 
Alkyne-EG6GRGDSP Peptide Specialty Laboratories GmbH, 
Heidelberg, Germany  
Ampicillin  Gold Biotechnology, Inc.®, St. Louis, MO, USA 
Ascorbic acid Merck, Darmstadt, Germany 
Bovine serum albumin, BSA Merck, Darmstadt, Germany 
Conc. hydrochloric acid Merck, Darmstadt, Germany 
Conc. sulphuric acid Merck, Darmstadt, Germany 
Copper sulfate, CuSO4 Merck, Darmstadt, Germany 
Cyanobocalamin, Cbl (B12) Merck, Darmstadt, Germany 
Cyclic Arg-Gly-Asp-alkyne, cRGD-alkyne Biotrend, Köln, Germany 
Deoxynucleotide triphosphates, dNTP Agilent Technologies, Santa Clara, CA, USA 
Digestion buffer 10x Agilent Technologies, Santa Clara, CA, USA 
Dimethylsulfoxid, DMSO Merck, Darmstadt, Germany 
Dithiothreitol, DTT Merck, Darmstadt, Germany 
DNA Loading Dye 6x Biolabs®Inc., Ipswich, MA, USA 
Dpn1 Biolabs®Inc., Ipswich, MA, USA 
Duebecco’s Modified Eagle Medium, DMEM Thermo Fisher Scientific, Carlsbad, CA, USA 
Ethanol Carl Roth, Karlsruhe, Germany 
Ethylacetate Merck, Darmstadt, Germany 
Ethylendiaminetetraacetat, EDTA Merck, Darmstadt, Germany 
Fetal bovine serum, FBS Merck, Darmstadt, Germany 
Hydrogenperoxide AppliChem GmbH, Darmstadt, Germany 
Imidazole Merck, Darmstadt, Germany 
Integrin fragment !"#3 R&D Systems, Minneapolis, Minnesota, USA 
Isopropyl #-D-1-thiogalactopyranoside, IPTG Gold Biotechnology, Inc.®, St. Louis, MO, USA 
L-Glutamine Thermo Fisher Scientific, Carlsbad, CA, USA 
Lysogeny Broth, LB powder (Luria/Bertani) Carl Roth, Karlsruhe, Germany 
Magnesium chloride Merck, Darmstadt, Germany 
Manganese (II) chloride Grüssing GmbH, Filsum, Germany 
Materials 
! !(-!
Methanol Carl Roth, Karlsruhe, Germany 
MOPS 20x buffer Thermo Fisher, Carlsbad, CA, USA 
Nickel (II) chloride Merck, Darmstadt, Germany 
Nitrilotriaceticacid-alkyne, NTA-alkyne Synthesized in this lab 
Paraformaldehyde, PFA Riedel de Haen, Hannover, Germany 
Penicillin/Streptomycin, PenStrep Thermo Fisher, Scientific Carlsbad, CA, USA 
Phalloidin TRITC Merck, Darmstadt, Germany 
Phenylmethanesulfonylfluoride, PMSF Merck, Darmstadt, Germany 
Phosphate buffered saline, PBS Merck, Darmstadt, Germany 
Polyethyleneglycoazide, PEGazide IRIS Biotech, Marktredwitz, Germany 
Polyethyleneglycol, PEG2000 RAPP Polymere, Tübingen, Germany 
Q5 DNA Polymerase NEB, Ipswich, Massachusetts, USA 
Quick load ladder Biolabs®Inc., Ipswich, MA, USA 
SERVA DNA Stain G Serva Electrophoresis, Heidelberg, Germany 
Sharp Pre-stained prot-standard, Intermer Typ 
XC13 
 Thermo Fisher Scientific, Carlsbad, CA, USA 
Sodium chloride Merck, Darmstadt, Germany 
Sodium dodecyl sulfate, SDS Carl Roth, Karlsruhe, Germany 
Sodium hydrogenphosphate Merck, Darmstadt, Germany 
Stempro® Accutase Thermo Fisher Scientific, Carlsbad, CA, USA 
Toluene Merck, Darmstadt, Germany 
Triethylamine Merck, Darmstadt, Germany 
Tris Carl Roth, Karlsruhe, Germany 
Triton X-100 Merck, Darmstadt, Germany 
 
Deionized water was used in all experiments. The water was purified by a MilliQ® 
Integral water treatment plant (Merck, Darmstadt, Germany) or ELGA Labwater 
(Veolia Water Technologies, Celle, Germany). If an experiment is executed in normal 
water it will be indicated in the text. 
  
! ).-! /01"234"56!
! ($!
8.2 Antibodies 
Epitope Isotope Conjugation Cat. number Distributor 
Vinculin Mouse, IgG  V9131 Merck 
Zyxin Rabbit, IgG  Z4751 Merck 
Mouse-IgG Donkey Alexa647 A-31571 Thermo Fisher Scientific 
Rabbit-IgG Goat Alexa488 A-11034 Thermo Fisher Scientific 
6x His-tag Rabbit  Ab9108 Abcam 
8.3 Kits 
For purification of plasmids the QIAprep Spin Miniprep Kit (Qiagen, Venlo, 
Netherlands) was used. For site-directet mutagenesis the QuikChange II Site-Directed 
Mutagenesisi Kit (Agilent Technologies, Santa Clara, CA, USA) was used. 
8.4 Cell Lines and Bacteria Strains 
U-2 OS (human osteosarcoma cells, ATCC) and MCF 7 (human adenocarcinoma cells, 
ATCC) were used for cell adhesion studies. Electro competent E. coli (DH5!), were used 
for plasmid amplification. The proteins were expressed in chemo competent E. coli 
strain BL21DE* and NiCO, and purified as described in chapter 7.2. Generation of 
electro and chemo competent E. coli is described in chapter 7.1.1. 
8.5 Buffers and Media 
8.5.1 LB Medium for E. coli Culture 
For cultivating E. coli, LB powder (Luria/Miller) 20 g/L was autoclaved. LB Agar plates 
were produced from autoclaved LB Agar (7.5 g Agar, 10 g LB medium per 500 mL) and 
selective antibiotics were added prior plate pouring.  
 
8.5.2 Mammalian Cell Culture Media 
 
Growth medium for cell-lines 
DMEM with: 4.5 g/L D-Glucose, 1 mM Sodium 
pyruvate, Phenol Red 
Supplements: 4 mM L-Glutamine, 10 % v/v FBS, 1 % 
v/v Pen Strep 
 
Adhesion study medium  
DMEM with: 4.5 g/L D-Glucose, 1 mM Sodium 
pyruvate, Phenol Red 
Supplements: 4 mM L-Glutamine, 1 % v/v Pen Strep 
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8.5.3 Buffers 
 
Buffer A 300 mM NaCl, 50 mM TRIS pH 7.4 
Integrin Binding Buffer 150 mM NaCl, 50 mM TRIS pH 7.4, 2 mM MgCl2, 1 
mM MnCl2 
Elution Buffer 300 mM NaCl, 50 mM TRIS pH 7.4, 250 mM 
imidazole 
TAE Buffer 40 mM Tris pH 8.5, 20 mM Acetic acid, 1 mM EDTA  
Coomassie Staining 0.1 % (w/v) Coomassie brilliant blue, 50 % (v/v) 
Methanol, 10 % (v/v) Glacial acetic acid, 40 % (v/v) 
water 
Destain Buffer 10 % (v/v) Acetic acid, 50 % (v/v) Ethanol 
8.6 Disposables 
 
Cell culture flask 25 cm2 Greiner Cellstar®, Sigma Aldrich, Germany 
Cell culture flask 75 cm2 Greiner Cellstar®, Sigma Aldrich; Germany 
Coverslips, 20x20 mm, standard thickness # 1 Roth, Germany 
Object slide Roth, Germany 
Multiwell culture plates Greiner bio one, USA 
Stericup sterile filter device, 0.22 µm Rotilabo®, Roth, Germany 
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9. Methods 
 
9.1 Synthesis of Protein Mutants 
9.1.1 Cloning 
i) Plasmids and Primer 
The LOV2-ipaA plasmid was kindly provided by Brian Kuhlman (Addgene plasmid # 
40236). The CarH plasmid was kindly provided by Fei Sun. 
 
Table 2: Specification of original plasmids. 
Plasmid name Vector and Coding Gene Selection Marker 
LOV2-ipaA pET21b-LOV2-ipaA Ampicillin 
CarH pET22b-CarH Ampicillin 
 
The LOV2-ipaA sequence was mutated to create LOV2 protein. Derivatives were 
produced by insertion of point mutations. All sequences, and templates are listed in 
the appendix. The primers were customized synthesized by Eurofins®. The standard 
protocol described in the QuikChange II Site-Directed Mutagenesis Kit was used for 
introducing point mutations. Plasmids were isolated using the QIAprep Spin 
Miniprep Kit.  
 
ii) Insertion of point mutations 
For the polymerase chain reaction (PCR) the following reagents were gently mixed 
by pipetting: 
@! 0.2 µL forward primer (10 µM in water) 
@! 0.2 µL reverse primer (10 µM in water) 
@! 1.5 µL 10x reaction buffer (Buffer of PFU Polymerase) 
@! 0.2 µL template plasmid (100 µg/µL in water) 
@! 7.5 µL water 
@! 0.2 µL deoxynucleotide triphosphates, dNTPmix 
After addition of 0.2 µL Q5 polymerase, the PCR tube was transferred immediately to 
the PCR machine (DNA engine, Peltier thermal cycler T-100, BioRAD, USA). 18 PCR 
cycles were performed, each consisting of the following three phases after an initial 
melting at 97 °C for 3 min:  
@! 97 °C for 30 s 
@! annealing temperature for 30 s 
@! 72 °C for 0.5 min/kDa 
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The annealing temperature was varied between 65 °C - 75 °C depending on the 
primers. After a final elongation time of 5 min at 72 °C, 0.2 µL of DpnI (10 units/µL) 
were added and the solution was incubated at 37 °C for 1 h. After completion of the 
DpnI digestion, the PCR reaction was incubated on ice to stop the enzymatic activity. 
1.0 µL PCR product was mixed with 5 µL 5x DNA loading dye and separated via 
agarosegel electrophoresis (0.8 % w/v Agarose in TAE buffer and 12 µL SERVA DNA 
Stain G with a Quick load ladder as marker to confirm the PCR reaction product. 
 
iii) Transformation in Electro Competent E. coli 
48 µL pre-chilled electro competent E. coli (106 cells/150 µL in glycerol) were 
transferred into a pre-chilled 1.5 mL tube, and 2 µL of the plasmid (100 ng/µL) was 
added on ice. The solution was gently mixed 2-3 times and transferred in a pre-chilled 
electroporator cuvette (1 mm distance from Sigma Aldrich). The E. coli were pulsed 
(GenePulser Xcell™, BioRAD, USA, voltage 1800 V, capacity 25 µF, resistance 200 $) 
and 450 µL pre-heated (37 °C) LB medium was immediately added afterwards. The 
bacteria solution was transferred into a 1.5 mL tube and incubated at 37 °C and 
240 rpm for 1 h. Subsequently the bacteria solution was plated on ampicillin agar 
plates and incubated at 37 °C overnight. For plasmid amplification, colonies were 
picked from each plate and transferred to separate 15 mL falcon tubes each 
containing 10 mL LB medium with 100 µg/mL ampicillin. The cultures were grown at 
230 rpm and 37 °C, overnight. 
 
iv) Plasmid Purification 
The plasmid purification was done with the QiAprep®Spin Miniprep Kit (Qiagen, 
Germany). The bacteria from the overnight cultures were spun down in a table-top 
centrifuge at 6000 rpm and RT for 10 min (Rotina 380R, Hettich Zentrifugen). The 
supernatant was discarded, and the bacteria pellet was resuspended in 250 µL P1 
buffer and transferred into a 1.5 mL eppendorf tube. 250 µL P2 lysis buffer was added 
and the solutions were gently mixed by inverting the vial 5 times. After 2 min 
incubation time, 350 µL N3 neutralization buffer was added and mixed by inverting 
the vial several times. Subsequently the precipitant was spun down in a table-top 
microcentrifuge at 13000 rpm and RT for 10 min (Centrifuge 5418, Eppendorf, 
Germany).  
The DNA containing supernatant was applied on a QIAprep® spin column and 
centrifuged at 13000 rpm and RT for 1 min. The flow-through was discarded, and the 
column was washed with 750 µL PE buffer. Then the column was transferred to a fresh 
1.5 mL tube, and 40 µL elution buffer was applied and incubated on the column for 
2 min before centrifuging at 13000 rpm and RT for 1 min. The concentration of the 
flow through was determined with NanoDrop (ND-1000 V3, peQLab Biotech GmbH, 
USA) and sent in in a concentration of 100 ng/µl for sequencing (seqlab®, Germany). 
  
! *.-! ;<315"0!ABC<566"30!
! ((!
v) Preparation of Chemo Competent E. coli 
100 mL LB medium was inoculated with Bl21DE* from the glycerol stock and 
incubated at 240 rpm and 37 °C till an optical density of 4.2. The optical density at 
600 nm of the bacterial culture was determined with an UV-Vis spectrometer 
(Lambda25, PerkinElmer, Germany). The culture was cooled on ice for 10 min, divided 
into two fractions and spun down at 4 °C at 6000 rpm for 10 min (Avanti® J-26 XP, 
Beckman Coulter, USA, rotor: JA 10). After removal of the supernatant the pellets 
were separately resuspended in 30 mL ice cold buffer (80 mM MgCl2, 20 mM CaCl2) 
and the pellet was recovered by a second centrifugation step with the settings 
mentioned before. Hereafter the bacteria were resuspended and recovered for a 
second time as described before and finally each pellet was resuspended in 2 mL ice 
cold 0.1 M CaCl2 solution. To each solution 70 µL DMSO was added, mixed and 
incubated on ice for 15 min. Finally, another 70 µL DMSO was added to each solution. 
The so derived solution was aliquoted, freeze dried immediately on dry ice and stored 
at -80 °C till further use. 
 
vi) Preparation of Electro Competent E. coli 
1 L LB medium was inoculated with DH5! from the glycerol stock and incubated at 
240 rpm and 37 °C till an optical density of 0.4. The culture was harvested by spinning 
down at 4 °C at 6000 rpm for 10 min (Avanti® J-26 XP, Beckman Coulter, USA, rotor: 
JA 10). After removal of the supernatant the pellet was resuspended in 450 mL ice 
cold deionized water and the pellet was recovered by a second centrifugation step 
with the settings mentioned before. Hereafter the bacteria were resuspended and 
recovered for a second time as described before and finally the pellet was 
resuspended in 40 mL ice cold 10 % v/v glycerol and recovered by centrifugation. 
After removal of the supernatant the pellet was resuspended in 3 mL ice cold 10 % 
v/v glycerol, freeze dried immediately on dry ice and stored at -80 °C till further use. 
9.2 Protein Expression 
9.2.1 Transformation of Chemo Competent E. coli 
50 µL chemo competent E. coli BL21DE* or NiCO (106 cells/150 µL) were mixed with 
0.5 µL purified plasmid (100 ng/µL) and incubated on ice for 20 min. The 
transformation was performed by heat shock at 42 °C for 1 min (Thermomixer 
comfort, Eppendorf, Germany). Thereafter, the bacteria were cooled down on ice for 
2 min before adding 750 µL LB medium and incubating at 37 °C at 230 rpm for 1 h. 
Finally, the bacteria solution was plated on a selective ampicillin LB-agar plate and 
incubated at 37 °C overnight. 
9.2.2 Protein Expression 
One colony from the selective BL21DE* or NiCO agar plate was picked and transferred 
into a 15 mL falcon tube containing 10 mL LB medium with 100 µg/mL ampicillin. The 
bacteria solution was incubated at 230 rpm and 37 °C overnight. The 10 mL overnight 
culture was transferred into 1 L LB medium with 100 µg/mL ampicillin and incubated 
at 37 °C for 3 h. At an optical density of 0.80 – 1.0, the temperature of the incubator 
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was reduced to 16 °C for 15 min and afterwards 500 µL isopropyl #-D-1-
thiogalactopyranoside (IPTG, 1 M) solution (final concentration 0.5 µM) was added to 
the bacteria solution to induce expression of the His-tagged protein of interest. The 
IPTG-induced bacteria were incubated at 230 rpm and 16 °C overnight. 
9.2.3 Protein Purification 
The overnight bacteria cultures that express the protein of interest were spun down 
at 4 °C at 6000 rpm for 10 min (Avanti® J-26 XP, Beckman Coulter, USA, rotor: JA 10). 
The supernatant was discarded and the bacteria pellet was transferred to a pre-
chilled 50 mL falcon. The bacteria pellet was resuspended in 20 mL buffer A with 
1 mM phenylmethylsulfonylfluoride (PMSF, 100 mM in methanol) and 1 mM 
dithiothreitol (DTT, 1 M in water). Thereafter, the bacteria were ruptured by 
sonication (OMNI sonic ruptor 400, OMNI international, USA; Settings: 40 % pulse, 
50 % frequency, 10 min). The obtained lysate was transferred to a pre-chilled 
centrifuge tube and spun down at 4 °C and 12000 rpm for 30 min (Avanti® J-26 XP, 
Beckman Coulter, USA, rotor: JA 25.5). 
The supernatant was filtered through a 0.45 µm cellulose filter. The obtained protein 
solution was purified over a Ni2+-NTA column (Ni-NTA, Superflow cartridge, Qiagen) 
in the Äkta HPLC system. Before, the column was equilibrated with 25 mL buffer 
(300 mM NaCl, 50 mM Tris pH 7.4, 30 mM imidazole). The protein was loaded over a 
superloop (50 ml, GE Healthcare, USA), washed with 10 mL loading buffer and eluted 
with a gradient from 50 % - 100 % elution buffer over 15 mL, applying a flow of 
1 mL/min. 
The purified protein was dialysed against buffer A to remove the imidazole (Dialysis 
membrane, SpectraPor®, MWCO = 10 kDa) overnight exchanging the buffer two times. 
The protein concentration for LOV2RGD mutants was determined absorption 
measurement at 473 nm (after 5 min relaxation time in dark) assuming an extinction 
coefficient of 9200*1/Mcm.(97) 
The CarH tetramer complex was assembled upon addition of a four-fold molar excess 
of vitamin B12 to the monomer solution in the dark and incubation at 4 °C overnight. 
The obtained tetramer was further purified utilizing a size exclusion column 
(Quiagen, HiLoad 16/600, Superdex 200 pg) with buffer A as fluid phase. The retention 
time of the tetramer was 75 min, as shown in the appendix. 
9.2.4 SDS-PAGE 
The protein (LOV2RGD mutants and CarH monomeres) purity was assessed by SDS-
PAGE (4-12 % Bis-TRIS; Thermo Fisher Scientific). For that purpose, 4 µg protein was 
mixed with 4x loading dye and denatured at 97 °C for 10 min. For the SDS-PAGE 20 µL 
pre-mixed solution per condition was used. The gel was run in MOPS buffer at 200 V, 
160 A for 40 or 50 min. The gel was stained with coomassie brilliant blue staining 
solution (0.025 g/L in glacial acetic acid/methanol/water 10/45/45 ml) for 5 min and 
heating to the boiling point and afterwards destained in destain buffer while shaking 
at RT, overnight. The images of the SDS-Pages can be found in the appendix. 
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9.3 Characterization of Mutants 
9.3.1 Kinetic Studies 
To measure the recovery of the specific absorption of the flavin mononucleotide after 
excitation, the LOV2RGD mutant sample was illuminated with blue light (470 nm) for 
1 min. A spectrum was recorded every 18 s with a UV-Vis spectro-photometer to 
observe the recovery of the flavin mononucleotide starting 1s after the illumination. 
Representatively for the spectra of all examined mutants, the spectrum of PHii 77 is 
shown in section 5.3.1. To obtain the half-live of the dark state recovery, the 
absorption maximum at 450 nm is plotted over time and fitted to a first order 
kinetics. 
The CarH tetramer were stepwise illuminated with a green LED (515 nm – 520 nm) to 
monitor the successive disassembly of the tetramer. The spectrum was recorded with 
a plate reader (Tecan infinite M200, Tecan, Männedorf, Switzerland) using an 
integration time of 5 – 10 s, up to a final illumination time of 1 min. 
9.3.2 QCM-D Measurements 
The gold QCM-D crystals (E4, Q-sense, Sweden), were activated with UV-ozone (UVO 
cleaner, Model NO342-220, Jelight Company Inc, USA) for 10 min. Each surface was 
coated with 50 µL of a solution containing 32.4 µM HS-(CH)11-EG6-N3 (Prochimia, 
Sopot, Poland) and 20 µM HS-(CH)11-EG3-OH (Prochmia, Sopot, Poland) diluted in 
buffer A on parafilm at RT for 1 h. The azide groups were clicked with NTA-alkyne 
according to the protocol described in 7.3.2. Afterwards, the crystals were washed 
twice with buffer A, once with 50 mM EDTA (pH 7.4), once with buffer A and dried 
under a stream of nitrogen. All measurements were performed at 25 °C with a pump 
speed of 0.2 mL/min. The QCM-D measurements were performed in dark following 
the protocol stated below. For monitoring the binding of integrin to the protein 
coated surfaces, the integrin fragment !"#3 (R&D Systems, MN, USA), 100 µg/ml) was 
used. 
 
QCM-D protocol: 
1) 10 min buffer A 
    2) 30 min CarH3.2 tetramer (400 µL) 
    3) 10 min buffer A 
    4) 10 min integrin binding buffer 
    5) 300 µL integrin fragment (16.6 µg/ml) 
    6) 10 min integrin binding buffer 
7) 20 min green light illumination in one chamber, 
the other kept in dark, constant washing with 
integrin binding buffer in both chambers 
    8) 10 min buffer A 
    9) 10 min elution buffer 
    10) 10 min buffer A 
 
After the measurements, the crystals and the chambers were cleaned with 2 % (v/v) 
SDS in water for 10 min, followed by incubation with deionized water for 10 min and 
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drying under a nitrogen stream. The crystals were further cleaned via UV-ozone for 
10 min and incubated in basic ammonia hydrogen peroxide containing a (v/v/v) 
ration of water/ammonia (25 %)/hydrogen peroxide of 5/1/1 at 75 °C for another 
10 min. Subsequently the crystals were washed several times with water and dried 
under a stream of nitrogen before further usage. 
9.3.3 Competitive Fluorescence Binding Assay 
The competitive fluorescence binding assay was performed at a Clario Star plate 
reader (BMG Labtech, Ortenberg, Germany), which was kindly provided from Prof. 
Dr. Mayer at ZMBH (Zentrum für Molekulare Biologie, University Heidelberg, 
Germany). The experiments were measured in a black 384 well plate (Corning, flat 
bottom, black, Ref 3820) with a LP5966 dichroic filter with an excitation maximum at 
540 nm (bandwidth 20 nm) and emission maximum at 590 nm (bandwidth 20 nm). 
The assay is based on the effect that fluorophores excited with linear polarized light 
will emit also polarized light. By determining the anisotropy value, which is the ratio 
of the parallel and vertical perpendicular light (equation 1), the rotational freedom 
of the fluorophore is displayed. A free fluorophore sustains the exited polarization in 
its fluorescence to a lower extent than a bound fluorophore and therefore exhibiting 
a lower anisotropy value. 
 
Equation 1:    ! " # $%#&#'($)$%*#+'($) 
 
A = anisotropy, III = intensity of parallel polarized light, I% = intensity of perpendicular 
polarized light and G = grating factor 
 
The grating factor is an instrument dependent correction factor and that determines 
the detectors sensitivity for the respective polarization direction. To design an assay 
based on fluorescence anisotropy, a small fluorophore should bind to a comparable 
big binding partner. In our case, we designed the fluorophore based on TAMRA 
conjugated with a RGD sequence (MW: 960 g/mol) as displayed in Figure 4, which is 
bound by the integrin heterodimer !#"3 (MW:191300 g/mol). 
 
 
Figure 9.1: Structure of TAMRA-RGD fluorophore. 
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Since the integrin has 10-fold the mass as the TAMRA-RGD conjugate, it is suitable for 
fluorescence anisotropy measurements. TAMRA has an excitation wavelength of 
543 nm and an emission of 576 nm. 
For determination of the Kd1 of integrin a titration of TAMRA-RGD (200 nM in 
deionized water) with integrin fragment (100 µg/ml, !"#3 (R&D Systems, MN, USA),) 
was performed at RT. An incubation time of 30 min was needed to reach the 
equilibrium after each addition step. Therefore, the components were always 
incubated for this complex formation time. The complex was found to be stable over 
a time of more than 330 min. 
The competitive binding assay was performed in triplicates. Therefore, the initial 
complex of 20 nM fluorophore and 60 nM integrin fragment was preformed in dark 
at RT for 45 min. Afterwards, increasing concentrations of LOV2RGD solution (stock, 
10 µM) were added to the initial solution. After each step the solution was incubated 
in dark for 30 min, measured and equilibrated under blue light illumination for 
additional 30 min (5.35 mW/cm2) before measuring the lit state. The following 
pipetting scheme was applied: 
 
Table 3: Volume of LOV2-RGD mutant solution added to the preformed TAMRARGD/integrin complex 
and the obtained concentration. 
Volume protein solution [µL] 
(stock c =10 µM) 
Final concentration [nM] 
0.75 244 
0.75 476 
1.5 909 
3 1666 
6 2857 
12 4444 
 
The obtained curves were fitted with the Hill1 equation in Origin (OriginLab, 
Northamton, Massachusetts, USA), assuming the first data point of the pure TAMRA-
RGD/integrin complex as a fixed starting point. From the fits the concentration of 
LOV2RGD mutants can be determined that are required to replace half of the TAMRA-
RGD fluorophore in the TAMRA-RGD/integrin complex. With the obtained 
concentration for LOV2RGD the Kd2 value of the competing equilibrium can be 
calculated as described in 5.3.2. 
As a control the ion dependency of the integrin binding was tested by using buffer A 
instead of integrin binding buffer in the titration assay. The specificity of the binding 
was determined by using the unmodified LOV2 domain as a competitor, and as a 
positive control cRGD (circular-RGD-alkyne, Biotrend, Köln, Germany) instead of the 
LOV2-RGD mutant was used as a ligand. The respective spectra are listed in the 
appendix. 
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The reversibility of the LOV2-RGD mutant binding to TAMRA-RGD was tested for 
PHii 7 and RGD 77. Therefore, the concentration of LOV2-RGD mutant required to 
replace half of the fluorophore from the TAMRA-RGD/integrin complex was added 
to the solution of the preformed TAMRA-RGD/integrin complex and incubated for 
initial 45 min. After 15 min blue light illumination, the anisotropy of the lit state was 
measured. The solution was always relaxed for 30 min in the dark or for 15 min under 
blue light illumination before recording of the next data point. The switching was 
monitored for 3 cycles. 
9.4 Surface Functionalization 
9.4.1 Surface PEGylation 
Figure 9.2: Surface functionalization and passivation with polyethylene glycols (PEGs). 
For the surface preparation, 20x20 mm2 glasscoverslips were cleaned with 
peroxymonosulphuric acid (H2SO5) (formed by 3:1 sulphuric acid (H2SO4) and 
hydrogen peroxide (H2O2)) for 1 h. After removal of the acid by washing three times 
with water, the surfaces were dried with a stream of nitrogen. In a flask 12 mg silane-
PEGazide (MW: 3245 g/mol; Rapp Polymere, Tübingen, Germany) were dissolved in 
35 mL dry toluene (0.98*10-11 mM) and 10 µL triethylamine (final concentration 
25 µM) under nitrogen atmosphere. The cleaned surfaces were placed into the PEG-
containing solution under nitrogen atmosphere and kept at 78 °C overnight. 
Afterwards, the surfaces were first sonicated in ethyl acetate and then in ethanol for 
5 min each. Finally, the surfaces were dried under a stream of nitrogen before further 
modification. 
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Surfaces were coated with different densities to study the effect of ligand distribution 
on cell adhesion. Therefore, the silane-PEGazide was mixed in different molar ratios 
with silane-PEGmethoxy (MW: &2000 g/mol; Rapp Polymere, Tübingen, Germany). 
 
Table 4: Used concentrations and masses of the respective silanePEGs to yield different surface densities 
of clickable silanePEGazide.  
Ligand density [%] silanePEGazide [mg] silanePEGmethoxy [mg] 
0.2 0.0032 4.8 
1 0.0157 7.35 
2.5 0.0394 4.3 
10 0.1575 4.39 
25 0.3938 3.01 
40 0.63 2.03 
50 0.7875 1.45 
100 15 - 
 
Following functionalization, the surfaces were further modified with NTA-alkyne like 
described in chapter 7.3.2 and incubated with LOV2RGD 77. According to 7.4.2 U-2 OS 
cells were seeded onto the surfaces. After 2 hours, the medium was removed and cells 
were fixed with 1 mL of 4 % (w/v) paraformaldehyde (PFA) solution in PBS per well at 
RT for 20 min. Surfaces were mounted in mowiol supplements with 0.75 µL/mL DAPI 
to stain the nuclei. Immunofluorescence imaging was carried out as described in 7.4.7 
followed by image analysis with imageJ (see section 7.4.9). 
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9.4.2 Click Reaction on PEGazide Functionalized Surfaces 
!!
Figure 9.3: Click reaction for PEGazide functionalization. 
The passivated surfaces were incubated in a humid chamber at RT in 100 µL reaction 
solution each for 2 h. The reaction solution for NTA-functionalization contains: 
100 µM Tris pH 9.5, 100 µM ascorbic acid, 150 µM NTA-alkyne, 1 mM CuSO4 in water. 
The reaction solution for cRGD functionalized surfaces contains: 100 µM Tris pH 9.5, 
100 µM ascorbic acid, 150 µM cRGD-alkyne (100 mM, BioTrend, Köln, Germany), 1 mM 
CuSO4 in water. 
The NTA functionalized surfaces were washed twice with buffer A, once with 50 mM 
EDTA pH 7.4 in water and once with buffer A. Afterwards the surfaces were incubated 
with 100 mL 0.1 M NiCl2 solution each at RT for 5 min. The surfaces were washed once 
with buffer A and stored in buffer till further modification. The cRGD functionalized 
surfaces were washed with water and dried in a stream of nitrogen. 
To coat the surfaces with protein, they were incubated with 100 µL protein solution 
(10 µM in buffer A) at RT for 30 min. 
9.4.3 Determination of Protein Immobilization 
The amount of CarH tetramer immobilized on the surfaces was assessed with 
detection of the Histag with antibodies. Therefore, two surface were washed with 1 % 
BSA solution in PBS at RT in dark for 20 min. One surface was illuminated for 10 min 
with green light, washed once with with 1 % BSA solution in PBS for 5 min while the 
other was kept in dark. Both surfaces were fixed with 4 % w/v PFA in water at RT for 
20 min and washed with 1 % BSA solution in PBS for 5 min in dark. As a negative 
control a pegylated surface without protein was taken, blocked with 1 % BSA solution 
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in PBS at RT in dark for 20 min and fixated and washed like described above. The 
respective surfaces were incubated with 100 µL each with 1 % BSA, 1/300 anti-His 
rabbit IgG (Ab9108, Abcam) at RT in dark for 30 min. The surfaces were washed with 
1 % BSA in PBS solution three times for 5 min each. The surfaces were incubated with 
100 µL each with 1 % BSA in PBS and 1/500 Alexa488 goat anti-rabbit IgG (A-11034, 
Thermo Fisher Scientific) and phalloidin-TRITC (2 µg/mL) at RT in dark for 2.5 h. The 
surfaces were washed twice with PBS and mounted with 20 µL mowiol containing 
0.75 µg/mL DAPI upside down on a glass slide.  
9.5 Cell Experiments 
9.5.1 Cell Culture 
For adhesion studies with LOV2RGD mutants, U-2 OS (ATCC, USA) human 
osteosarcoma cells, an adherent epithelial cell line expressing several different 
integrin heterodimers were used. For adhesion studies with CarH mutants, MCF-7 
(ATCC, USA) human adenocarcinoma cells, also an adherent epithelial cell line, 
expressing several heterodimer integrins. In addition to cell-matrix contacts they 
also establish tight cell-cell contacts and form an epithelium. All cells were kept in 
growth medium (see section 6.4.2) at 37 °C, 5 % CO2 saturation in a humified 
atmosphere. Cells were subcultured every 2-3 days by detaching them with StemPro 
Accutase (Thermo Fisher Scientific, USA) and splitting them 1:5 in fresh growth 
medium. For adhesion experiments cell were seeded in serum free medium. 
9.5.2 Cell Seeding  
The NTA functionalized surfaces were each incubated with 100 µL of a 10 µM protein 
solution in buffer (300 mM sodium chloride, 50 mM TRIS pH 7.4) upside down on 
parafilm at 25 °C for 30 min. After incubation with the respective proteins, surfaces 
were washed with PBS buffer. Meanwhile cells were detached with 1 mL StemPro 
accutase at 37 °C for 5 min. The detached cells were resuspended and counted with a 
Neubauer Haemocytometer (2500 mm2, Laboroptik, Germany). 5000 cells/cm2 were 
seeded into each well in 2 mL serum free medium. Cells were either incubated under 
the irradiation of blue or green light (floraLEDs, PLANT CLIMATICS, Germany, light 
intensity: 25 µmol/m2s, blue light: 471 nm / or green light: 532 nm) or in the dark (at 
37 °C and 5 % CO2 for 2 h).  
9.5.3 Indirect Immunofluorescence of Focal Adhesion Proteins 
After 2 hours, the medium was removed and cells were fixed with 4 % (w/v) PFA 
solution in PBS at RT for 20 min. Subsequently, the fixing solution was removed, and 
each surface was washed twice with PBS buffer, treated with 1 mL 0.1 % (v/v) Triton 
X-100 in PBS buffer at RT for 5 min and washed with PBS buffer again. The surfaces 
were blocked with 1 mL 1 % BSA (w/v) in PBS at RT for 30 min. The respective surfaces 
were incubated with 100 µL of anti-vinculin mouse IgG (1 µg/mL in BSA in PBS) 
(V5255, SigmaAldrich) and anti-zyxin rabbit IgG (1 µg/mL in BSA in PBS) (Z4751, 
SigmaAldrich) at RT for 30 min. The surfaces were washed with 1 % (w/v) BSA in PBS 
three times for 5 min each. The surfaces were incubated with 100 µL Alexa647 donkey 
anti-mouse IgG (1 µg/mL in BSA in PBS) (A-31571, Thermo Fisher Scientific), Alexa488 
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goat anti-rabbit IgG (A-11034, Thermo Fisher Scientific) and phalloidin-TRITC 
(2 µg/mL) at RT in dark for 1 h. The surfaces were washed once with 1 % BSA in PBS 
and once with PBS and mounted with 20 µL mowiol containing 0.75 µg/mL DAPI 
upside down on a glass slide.  
9.5.4 Staining and Mounting 
In order to stain the cytoskeleton, each surface was fixed like afore mentioned, and 
subsequently incubated with 100 µL phalloidin-TRITC (2 µg/mL) in PBS buffer 
solution upside down on parafilm at RT for 30 min. Thereafter, each surface was 
washed twice with PBS buffer and mounted with 20 µL Mowiol containing DAPI 
(0.75 µg/mL) on a glass slide. After a polymerization time of 16 h the samples were 
imaged by fluorescence microscopy. 
9.5.5 Determination of Adhesion Area in Live Cell Experiments 
Surfaces were functionalized with PEGazide, NTA-alkyne and protein as described in 
section 7.3.2. The surfaces were glued into a homebuild incubation chamber. In brief, 
a 1.13 cm2 hole was cut into the bottom of a 35 mm diameter plastic petridish. The 
aforementioned surfaces were mounted with an addition-curing duplication silicone 
(Picodent Twinsil, Picodent, Wippenfürth, Germany) to cover the opening in the 
incubation chamber. The surfaces were washed once with PBS. Cells were seeded as 
described above in 2 mL serum free medium and incubated at 37 °C under 
illumination of 25 µmol*m-2s-1 blue light for 2 h. The change in the adhesion area was 
monitored with a DeltaVision Elite microscope system. The positions to be monitored 
were manually chosen under constant illumination (approximately 30 min). 
Afterwards, the cells were monitored with a 63x/1.4NA oil objective at 37 °C and 5 % 
CO2 under either blue light illumination (0.77 mW/cm2) or in dark for 3 h using 
interference reflection microscopy (IRM). As an excitation wavelength 632 nm with 
a bandwidth of 20 nm was chosen and an image was taken every 10 min. 
9.5.6 Metabolic Activity Test 
The influence of light on the metabolic activity of cells was determined with the 3-
(4,5-Dimethylthiozol-2-yl)-2,5-diphenaltetrazolium bromide (MTT) assay. Therefore, 
cells (U-2 OS for blue light, and MCF7 for green light) were seeded in a density of 50 
000 cells/0.3 cm2 in a 96 well plate in 100 µL complete growth medium. The cells were 
incubated at 37 °C exposed to the respective wavelength and light intensity for 2 h. 
The control was kept meanwhile in the dark. Afterwards 75 µL medium per well were 
removed and 10 µL MTT (saturated solution in PBS) was added. The cells were 
incubated at 37 °C in dark for 4 h. 50 µL DMSO per well was added and incubated at 
RT in dark for 10 min. The absorption at 540 nm was measured with a Tecan plate 
reader.  
9.5.7 Determination of Cell Number and Adhesion Area 
The cell number was determined by staining the nuclei with DAPI and cell area was 
derived via staining the cytoskeleton with phalloidin-TRITC. Therefore, wide field 
fluorescence images (Leica DM6000B, 10x, QAS filter set) of a stitched mosaic surface 
(12 mm2) were taken with the respective DAPI and TRITC filters.  
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9.5.8 Microscopy Settings 
Fluorescence Upright Widefield System 
 
Type: Leica DM6000B 
Used objectives: HCX PL Apo 10x/0.4 NA phase contrast 
Light source: HBO 
Camera: DFC 365FX 
Software: Leica LAS 
 
Epifluorescence filter setups: QAS, filter 
 
Fluorescence Inverted Widefield System 
 
Type: Delta Vision (GE healthcare, UK) based on Olympus IX inverted microscope 
(Olympus, Japan) 
Used objective: 60x/ 1.4 NA PlanApo oil (Olympus, Japan)  
Light source: HBO 
Incubator: homebuild 
Camera: Coolsnap HQ, Roper Scientific, USA 
Software: SoftWorx – version 6.5.2 
 
Epifluorescence filter setup: Alexa filter wheel, filter 632 nm/22 nm, IRM mode 
 
Confocal Laser Scanning Microscope 
 
Type: Zeiss, LSM 880 
Used objective 63x/1.4 NA oil (Zeiss) 
Laser:  UV diode:  405 nm 
Argon:  488 nm 
DPSS 561: 561 nm 
HeNe:  633 nm  
Incubator: PM 2000 RBT (PeCon, Germany) + CO2-module 
Detector: PMTs  
Software: Zen – version 2.1 SP3 
Methods 
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Inverted Phase Contrast Microscope 
 
Type: Leica DMi1 
Used objectives:10x 
Light source: HBO 
Camera: DFC 365FX 
 
9.5.9 Image Analysis 
Images were analysed using Fiji open source software (Version: 2.0.0-rc-59/1.15n). 
The threshold of the images was corrected manually and a binary image was 
generated. The cell number was calculated by using the plugin: “Analyse particles”, 
considering particles between 50 µm2 and 50 000 µm2. The spreading area of the cells 
on the respective surfaces was determined by picking at least 10 single images 
(1.2*10-3 µm2) and using Ilastik open source software (GNU General Public License) 
program to analyse the actin staining. Ilastik was trained to classify objects in three 
groups: single cells, overlapping cells and cell cut off from the picture edge. The 
pixels, which were taken into account as contributing to the spreading area were 
selected manually with one set of images and applied to all images analysed. Fitting 
and plotting of curves were done in OriginPro 2017G (OriginLab, Northampton, 
Massachusetts, USA) or Prism7.0d (GraphPad, San Diego, California, USA). 
9.5.10 Statistical Tests 
One way Anova test was employed for cell numbers in cell adhesion studies with 
CarH. The student t-test was employed for the statistical analysis of Kd2-values and 
cell numbers for LOV2RGD mutants. Mann-Whitney test was employed to assess the 
significance of the spreading area analysis in the cell adhesion experiments, in the 
static reversibility experiments as well as in the live cell reversibility experiments. In 
Box-plots the 10 - 90 % confidence interval is displayed. The box in box plots show 
the 25 % - 75 % confidence interval. p-values: * < 0.1, ** < 0.01, *** < 0.001, 
**** < 0.0001. 
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9.6 Synthesis of NTA-Alkyne 
!
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Synthesis protocol: 1 eq. 6-heptynoic acid (1.5 mmol, 0.2 ml) was dissolved in 100 eq. 
anhydrous dichloromethane. 2.5 eq. of N-Hydroxysuccinimide (NHS, 4.5 mmol, 
698 mg) and 1.5 eq. 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC, 
2.25 mmol, 349.3 mg) were added to the reaction solution. The solution was stirred 
under N2 atmosphere at RT overnight. The reaction was quenched upon the addition 
of 100 ml saturated NaHCO3 solution. The aqueous solution was extracted twice with 
50 ml diethylether. The combined organic phases were washed with 100 ml brine and 
100 ml water and dried with MgSO4. The filtered organic phase was removed under 
low pressure. Compound 1 was obtained as yellow crystals and used without further 
purification. 
 
 
 
4 eq. NaHCO3 (12 mmol, 1008.12 mg) was dissolved in 15 ml water and 1.2 eq N!- N!-
biscarboxylysine hydrate (3.6 mmol, 943.6 mg) was added. The solution was slowly 
added to a solution of 1eq. compound 1 (3 mmol, 621.3 mg) in 3 ml acetone and 30 ml 
ethanol. The reaction was stirred at RT for 48 h. The solvent was partially removed 
and 5 ml 0.25 M NaHCO3 solution was added. The precipitate was removed by 
filtration. The remaining solution was acidified with conc. HCl to pH 3 and the 
product was lyophilized. The yielded white chrystals were further purified by column 
chromatography. The eluent was ethanol/ethylacetate 3:1, which was exchanged to 
pure ethanol later on. The solvent was removed, yielding 0.676 mmol (250 mg). The 
nuclear magnetic resonance (NMR) spectrum was taken in D2O and a HR-ESI- was 
measured. 
 
% ppm (660 MHz): 3.76 – 3.74, m, 2*CH2, CH; 317-3.18, d, J = 5.4, CH2; 2.31, s, CH; 
2.25 – 2.16, m, 2*CH2; 1.89-180, d, J = 56.76, 2*CH2; 1.67-1.48, dquint, 1J = 7.56, 2J = 109.38, 2 
CH2; 1.55, m, CH2. 
 
HR-ESI-: m/z calculated C17H25N2O7- for [M-H]- : 369.17, found: 369.1671 
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Photo-Cleavable Cell Adhesion 
 
1 ATG GGC GAG CTC CCA GAA GAT CTG GGC ACC GGC CTG CTG GAA  
43 GCA CTG CTG CGC GGT GAT CTG GCG GGC GCC GAA GCT CTG TTT  
85 CGT CGT GGC CTG CGT TTC TGG GGC CCG GAA GGC GTT CTG GAG 
127 CAC CTG CTG CTG CCG GTG CTG CGT GAA GTG GGC GAA GCT TGG 
169 CAC CGT GGT GAA ATC GGC GTT GCA GAA GAA CAC CTG GCG AGC 
211 ACC TTC CTG CGC GCG CGT CTG CAG GAG CTG CTG GAC CTG GCA 
253 GGT TTC CCG CCG GGT CCG CCG GTC CTG GTG ACT ACG CCG CCG 
295 GGC GAA CGC CAC GAA ATC GGT GCG ATG CTG GCG GCG TAC CAT 
337 CTG CGT CGT AAG GGC GTC CCG GCG CTG TAT CTG GGC CCG GAT 
379 ACT CCG CTG CCG GAC CTG CGT GCA CTG GCG CGC CGC CTG GGT 
421 GCA GGC GCG GTC GTG CTG TCT GCT GTT CTG AGC GAA CCG CTG 
463 CGT GCT CTG CCT GAC GGT GCC CTG AAA GAT CTG GCA CCG CGT 
505 GTT TTC CTG GGC GGC CAG GGC GCA GGC CCG GAA GAG GCA CGC 
547 CGT CTG GGT GCC GAA TAC ATG GAA GAC CTG AAA GGC CTG GCT 
589 GAA GCG CTG TGG CTG CCG CGC GGT CCG GAA AAA GAA GCA ATC 
631 GGA TCC GGT CTC GAG CAT CAT CAT CAT CAT CAT 
Figure A1: Nucleobase sequence WT CarH without DNA binding sequence. 
 
1 MGELPEDLGT GLLEALLRGD LAGAEALFRR GLRFWGPEGV LEHLLLPVLR 
51 EVGEAWHRGE IGVAEEHLAS TFLRARLQEL LDLAGFPPGP PVLVTTPPGE!
101! RHEIGAMLAA YHLRRKGVPA LYLGPDTPLP DLRALARRLG AGAVVLSAVL!
151! SEPLRALPDG ALKDLAPRVF LGGQGAGPEE ARRLGAEYME DLKGLAEALW!
201! LPRGPEKEAI GSGLEHHHHH H*!
Figure A2: Amino acid sequence WT CarH without DNA binding sequence, top codon indicated with a 
star. 
 
CarH   LPRGPEKEAIGSGLEHHHHHH* 
CarH1   LPRGDEKEAIGSGLEHHHHHH* 
CarH2   LPRGPEKEAIGSGLQRGDHHHHHH* 
CarH3.1  PRGPEKEAIGSGLQRGDRGDHHHHHH* 
CarH3.2  PRGPEKEAIGSGLQRGDRGDRGDHHHHHH* 
CarH4.2  PRGPEKEAIGSGLQGRGDSPHHHHH* 
Figure A3: Amino acid sequences of CarH-RGD library. Introduced amino acids in bold, stop codon 
indicated with a star. 
 
Name Mutation 
CarH1 604     CCG ! GAC 
CarH2 643     GAG ! CAG insertion of CGC GGG GAC 
CarH3.1 643     GAG ! CAG double insertion of CGC GGG GAC 
CarH3.2 643     GAG ! CAG triple insertion of CGC GGG GAC 
CarH4.2 643     GAG ! CAG insertion of GGC CGC GGG GAC TCG 
CCG 
Figure A4: Mutation table of rendered or introduced nucleobases to yield CarH-RGD. 
  Photo-Cleavable Cell Adhesion 
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Figure A5: Chromatogram of the elute after size exclusion column. Blue curve: elute monitored at 
280 nm, red curve: elute monitored at 488 nm. Tetramer is eluted with a retention time of 70 min, 
indicated with the arrow, second peak is the CarH3.2 monomer, third peak is the cofactor vitamin B12.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6: SDS-PAGE gel of CarH-RGD mutants. Expected MW is 21 kDa. M indicates the marker with 
the expected bands in kDa on the left of each gel, the labels and the assigned proteins are shown in the 
table. 
 
 
 
Name Number 
CarH1 1 
CarH2 2 
CarH3.1 3 
CarH3.2 4 
CarH4.2 5 
M    1      2    3 4      5 
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Figure A7: Adhesion experiments of MCF7 cells to surfaces functionalized with the respective CarH-
RGD tetramer. Cells were incubated for 2 h in dark or under green light illumination (25 !M/m2s). Cell 
number normalized on the cell number adhered to surfaces covered with cRGD. As a passivation control 
a PEG-coated surfaces was used. 
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1 ATG CAT CAT CAT CAT CAT CAT GGC AGC CTG GCG ACC ACC CTG  
43 GAA CGT ATT GAA AAG AAC TTT GTG ATT ACC GAT CCG CGT CTG 
85 CCG GAT AAC CCG ATT ATT TTT GCG AGC GAT AGC TTT CTG CAG 
127 CTG ACC GAA TAT AGC CGT GAA GAA ATT CTG GGC CGT AAC TGC 
169 CGT TTT CTG CAG GGC CCG GAA ACC GAT CGT GCG ACC GTG CGT 
211 AAA ATT CGT GAT GCG ATT GAT AAC CAG ACC GAA GTG ACC GTG 
253 CAG CTG ATT AAC TAT ACC AAA AGC GGC AAA AAA TTT TGG AAC 
295 CTG TTT CAT CTG CAG CCG ATG CGT GAT CAG AAA GGC GAT GTG 
337 CAG TAT TTT ATT GGC GTG CAG CTG GAT GGT ACC GAA CAT GTG 
379 CGT GAT GCG GCG GAA CGT GAA GGT GTG ATG CTG ATC AAG AAA 
421 ACC GCG GAA AAC ATT GAT GAA GCG GCG AAA GAA CTG TAA 
Figure A8: Nucleobase sequence WT LOV2. 
 
1!  HHHHHHGSLA TTLERIEKNF VITDPRLPDN PIIFASDSFL QLTEYSREEI 
 51 LGRNCRFLQG PETDRATVRK IRDAIDNQTE VTVQLINYTK SGKKFWNLFH 
101 LQPMRDQKGD VQYFIGVQLD GTEHVRDAAE REGVMLIKKT AENIDEAAKE 
151 L* 
Figure A9: Amino acid sequence of WT LOV2, J!-helix indicated in red. 
 
Name Mutation 
RGD 1 391     GAA CGT GAA ! AGA GGT GAT 
RGD 2 394     CGT GAA GGC ! CGT GGT GAC 
RGD 3 415     AAG AAA ACC! AGA GGT GAC 
RGD 4 421     ACC GCG GAA! AGA GGT GAT 
RGD 5 430     AAC ATT GAT ! CGC GGT GAT 
RGD 6 442     GCG GCG AAA ! AGA GGT GAT 
RGD 7 448     AAA GAA CTG ! CGT GGT GAT 
RGD 7c 448     AAA GAA CTG ! GGC CGT GGT GAT and insertion 
of GAT TCG CCT  
RGD 8 442     GCG GCG AAA ! AGA GGT GAT depletion of the 
rest 
G ! A 400     GGT ! GCG 
I ! A 412     ATC ! GCG 
N ! E 430     AAC ! GAG 
PHSRNi 319     GAT CAG AAA GGC GAT! CCT CAC AGT CGC AAT 
PHSRNiii 367     ACC GAA CAT GTG CGT! CCC CAT TCT CGG AAT 
PHSRNii 22      Insertion of GGC GGC AGC CCG CAT TCG AGG AAC 
Figure A10: Inserted or substituted nucleobases to yield the respective LOV2-RGD mutants. The rest of 
the LOV2 sequence is preserved. 
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Figure A11: Amino acid sequences of LOV2-RGD library. Introduced RGD motifs in red, His-tag 
displayed in yellow, stabilizing amino acids in blue. 
LOV2:   DAAEREGVMLIKKTAENIDEAAKEL 
RGD 1:  DAARGDGVMLIKKTAENIDEAAKEL 
RGD 2:  DAAERGDVMLIKKTAENIDEAAKEL 
RGD 3:  DAAEREGVMLIRGDAENIDEAAKEL 
RGD 4:   DAAEREGVMLIKKRGDNIDEAAKEL 
RGD 5:   DAAEREGVMLIKKTAERGDEAAKEL 
RGD 6:  DAAEREAVMLIKKTAENIDERGDEL 
RGD 77:  DAAEREGVMLIKKTAENIDEAARGDRGD 
RGD 7:  DAAEREGVMLIKKTAENIDEAARGD 
RGD 7c:   DAAEREGVMLIKKTAENIDEAAGRGDSP 
RGD 8:  DAAEREGVMLIKKTAENIDRGD 
RGD 14:  DAARGDGVMLIKKRGDNIDEAAKEL 
RGD 24:  DAAERGDVMLIKKRGDNIDEAAKEL 
RGD 15:   DAARGDGVMLIKKTAERGDEAAKEL 
RGD 25:   DAAERGDVMLIKKTAERGDEAAKEL 
RGD 17:  DAARGDGVMLIKKTAENIDEAARGDRGD 
RGD 47:  DAAEREGVMLIKKRGDNIDEAARGDRGD 
RGD 1s:  DAARGDAVMLAKKTAENIDEAAKEL 
RGD 14s:  DAARGDAVMLAKKRGDNIDEAAKEL 
RGD 15s:  DAARGDAVMLAKKTAERGDEAAKEL 
RGD 1ss:  DAARGDAVMLAKKTAEEIDEAAKEL 
RGD 2s:  DAAERGDVMLAKKTAENIDEAAKEL 
RGD 3s:  DAAEREAVMLARGDAENIDEAAKEL   
RGD 4s:  DAAEREAVMLAKKRGDNIDEAAKEL 
RGD 5s:  DAAEREAVMLAKKTAERGDEAAKEL 
RGD 6s:  DAAEREAVMLAKKTAENIDERGDEL 
RGD 7s:  DAAEREAVMLAKKTAENIDEAARGDRGD 
PHSRNi RGD 1s: PHSRN_DAARGDAVMLAKKTAEAIDEAAKEL 
PHSRNi RGD 2s: PHSRN_DAAERGDVMLAKKTAENIDEAAKEL  
PHSRNi RGD 4s: PHSRN_DAAEREAVMLAKKRGDNIDEAAKEL 
PHSRNi RGD 7: PHSRN_DAAEREGVMLIKKTAENIDEAARGD 
PHSRNi RGD 77: PHSRN_DAAEREGVMLIKKTAENIDEAARGDRGD 
PHSRNiii RGD 2s: PHSRNDAAERGDVMLAKKTAENIDEAAKEL 
PHSRNiii RGD 4s: PHSRNDAAEREAVMLAKKRGDNIDEAAKEL 
PHSRNiii RGD 5s: PHSRNDAAEREAVMLAKKTAERGDEAAKEL 
PHSRNii RGD 2s: HHHHHHPHSRN … DAAERGDVMLAKKTAENIDEAAKEL 
PHSRNii RGD 4s: HHHHHHPHSRN … DAAEREAVMLAKKRGDNIDEAAKEL 
PHSRNii RGD 1s: HHHHHHPHSRN … DAARGDAVMLAKKTAENIDEAAKEL 
PHSRNii RGD 7: HHHHHHPHSRN … DAAEREGVMLIKKTAENIDEAARGD 
PHSRNii RGD 77: HHHHHHPHSRN … DAAEREGVMLIKKTAENIDEAARGDRGD 
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Name Number 
RGD 1 1 
RGD 2 2 
RGD 3 3 
RGD 4 4 
RGD 5 5 
RGD 6 6 
RGD 77 7 
RGD 7 8 
RGD 7c 9 
RGD 8 10 
RGD 14 11 
RGD 24 12 
RGD 15 13 
RGD 25 14 
RGD 177 15 
RGD 477 16 
RGD 1s 17 
RGD 14s 18 
RGD 15s 19 
RGD 2s 20 
Name Number 
RGD 3s 21 
RGD 4s 22 
RGD 5s 23 
RGD 6s 24 
RGD 7s 25 
RGD 1GIN 26 
PHi 1s 27 
PHi 2s 28 
PHi 4s 29 
PHi 7 30 
PHi 77 31 
PHiii 2s 32 
PHiii 4s 33 
PHiii 5s 34 
PHii 2s 35 
PHii 4s 36 
PHii 1s 37 
PHii 7 38 
PHii 77 39 
PHii 14s 40 
 
Figure A12: SDS-PAGE gel from LOV2-RGD mutants. Expected MW is 17 kDa. M indicates the marker with the 
expected bands in kDa on the left of each gel, the labels and the assigned proteins are shown in the table. On gel 
a) single mutants, on gel b) mutants with multiple RGD-motifs, c) mutants with stabilizing mutations, d) Mutants 
with PHSRN motif iii and i, and e) mutants with PHSRNii motif. 
a) b) 
c) d) 
e) 
Appendix 
! !+,,!
 
Figure A13: Control experiments of competitive fluorescence binding assay. a) The 
TAMRARGD/integrin complex was stable over time. b) No complex formation occurs with buffer 
without divalent ions even when protein concentration is increased. c) Low binding occurs when the 
WT LOV2 without RGD binding motif was added to the preformed TAMRARGD/integrin complex. d) 
As a positive control cRGD was used showing a Kd2 of 54 nM ± 3 nM. 
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Mutant Kd2,dark error Kd2,blue error Kd2,dark/Kd2,blue Significance 
RGD 7 3266 230 717 67 4.56 **** 
RGD 14 115 13 40 41 2.85 * 
PHi 77 654 45 235 26 2.78 *** 
RGD 77 912 343 347 78 2.63 * 
PHii 7 3157 747 1248 382 2.53 * 
PHii 77 805 162 323 43 2.49 ** 
RGD 7c 508 58 244 14 2.09 ** 
PHi 7 1009 273 506 104 1.99 * 
RGD 177 389 30 199 20 1.95 *** 
PHi 4s 69 9 36 7 1.91 ** 
PHii 1s 1467 423 783 315 1.87 ns 
RGD 1s 257 32 140 19 1.83 ** 
RGD 8 673 86 369 30 1.83 ** 
RGD 1 517 21 294 38 1.76 *** 
RGD 25 465 268 268 125 1.73 ns 
RGD 5 710 186 419 108 1.70 ns 
RGD 24 265 48 158 19 1.68 * 
PHi 1s 1709 410 1024 263 1.67 ns 
PHii 2s 2293 783 1381 541 1.66 ns 
RGD 2s 2093 462 1267 168 1.65 * 
RGD 14s 145 13 91 15 1.60 ** 
PHiii 4s 417 145 260 68 1.60 ns 
RGD 6 4169 226 2671 1152 1.56 ns 
PHii 14s 430 239 278 141 1.55 ns 
RGD 2 1285 243 832 287 1.54 ns 
RGD 7s 388 192 255 161 1.52 ns 
RGD 15s 237 19 157 17 1.51 ** 
RGD 6s 4584 766 3064 1032 1.50 ns 
RGD 3 959 484 642 284 1.49 ns 
RGD 5s 780 252 539 90 1.45 ns 
PHii 4s 418 212 288 131 1.45 ns 
RGD 1ss 373 126 260 141 1.43 ns 
PHi 2s 3136 609 2216 438 1.42 ns 
PHiii 5s 1076 196 783 211 1.37 ns 
RGD 477 149 2 110 2 1.36 **** 
RGD 4 594 70 442 26 1.34 * 
PHiii 2s 541 127 403 122 1.34 ns 
RGD 4s 906 169 682 233 1.33 ns 
RGD 15 206 24 164 56 1.26 ns 
RGD 3s 404 111 413 147 0.98 ns 
cRGD 54 3     
Figure A14: Kd2-values in dark and under blue light illumination, calculated as described in section 5.3.2 
from the competitive fluorescence anisotropy assay. Values in [nM]. Student t-test was used as 
statistical test. P-values are defined in section 9.5.10. 
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Figure A15: Cell adhesion studies of mutants combined with LOV2RGD 1s. a) Analysis of the cell 
number on the respective surfaces in dark or under 25 !M/ms blue light illumination. Experiments were 
conducted in triplicates. b) Analysis of the spreading area. Experiments were conducted in triplicates, 
cell number analyzed: n > 500, 10 - 90 % confidence interval is shown. 
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Figure A16: Analysis of the spreading area of the respective LOV2-RGD mutants on the left and the 
respective analysis of the normalized frequency on the right. 
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Figure A17: Reversibility of the spreading area of LOV2RGD mutants. Surfaces switched after 2 hours 
under blue light to dark for 1 additional hour, compared to surfaces kept always in the dark or under 
blue light illumination. The respective protein mutants do not show a reversion in the spreading area 
on the switched surfaces. 
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